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ABSTRACT 
UNDERSTANDING THE EFFECT OF BVDV ON INNATE IMMUNE RESPONSE 
THROUGH NEUTROPHILS 
NEELU SINGH THAKUR 
2017 
Bovine viral diarrhea virus (BVDV) is one of the highly prevalent and 
economically important diseases of cattle industry worldwide. The two major 
consequences of this disease are persistent infection and immunosuppression. Several 
studies have been done to determine the underline mechanisms of BVDV-induced 
immunosuppression targeting antigen presenting cells, adaptive immune system cells and 
cytokine gene expression. However, very little research has been done to determine the 
effect of BVDV on neutrophils. 
Neutrophils are one of the most abundant while blood cells (WBC) in the 
peripheral blood, which play a critical role in the innate as well as adaptive immune 
response. The current study measured the effect of BVDV infection on viability of 
neutrophils, their surface marker expression and functional abilities including 
migration/chemoattraction, phagocytosis, reactive oxygen species production (oxidative 
burst) and neutrophil extracellular trap (NET) formation. These studies revealed that none 
of BVDV strains affected the viability of neutrophils in vitro.  BVDV infection did affect 
surface marker expression.  TGAC and TGAN reduced the expression of CD18 and L-
selectin while increasing CD14 expression. All ncp BVDV strains used enhanced 
neutrophil migration while the cp BVDV strain reduced neutrophil migration as 
compared to mock-infected control treatment.  Among the BVDV strains used in current 
xv 
study, highly virulent 1373 significantly enhanced neutrophil migration. The 
enhancement in neutrophil migration by 1373 was approximately 55% higher as 
compared to LPS-treated positive control macrophages. 
BVDV infection significantly enhanced neutrophil phagocytosis activity for 0.2 
µm microsphere beads as compared to mock infection. Neutrophil phagocytic activity for 
rhodamine-labeled E. coli was reduced by BVDV infection as compared to LPS-control. 
TGAC, TGAN, 1373 or 28508 had 23%, 6%, 19% or 12% less phagocytic activity 
respectively as compared to mock-infected rhodamine-labeled E. coli-treated neutrophils. 
All BVDV strains used in the current study also reduced oxidative burst by 
approximately 50% as compared to positive control (p<0.05). In contrast, the four strains 
increased the neutrophil NET formation.  
The current study revealed that BVDV infection modulates neutrophil activity in 
a strain dependent manner. This effect may result in different disease outcomes, e.g. 
enhanced neutrophil migration by highly virulent 1373 may be the reason for severe 
neutropenia and hemorrhagic lesions in  in vivo infection. In addition to pathogenesis, 
further studies need to be done to determine the role of neutrophils in shaping adaptive 
immune system following BVDV infection. 
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UNDERSTANDING THE EFFECT OF BVDV ON INNATE IMMUNE RESPONSE 
THROUGH NEUTROPHILS  
 
CHAPTER 1 
RESEARCH OBJECTIVES AND LITERATURE REVIEW 
INTRODUCTION 
 
Bovine viral diarrhea virus (BVDV) is one of the major devastating problems in 
the cattle industry. BVDV infections produce variable and complicated symptoms 
including reproductive disorders, abortion, growth retardation, diarrhea, and lethal 
mucosal disease.  The greatest impact is likely from immunosuppression, which makes 
animals more susceptible to a vast variety of other pathogens including bacteria and 
viruses. Several studies have been conducted to evaluate the underline mechanisms of 
BVDV-induced immunosuppression and have targeted mainly adaptive immune cells.  
The current study was designed to investigate the effect of BVDV on a key cell of 
the innate immune system, the neutrophil.  Neutrophils are the first line of defense in the 
innate immune system along with macrophages and represent the largest population of 
circulating white blood cells (WBCs).  Neutrophils not only phagocytize and destroy the 
invading pathogen but also secrete a wide variety of cytokines and chemical mediators 
that help in shaping the adaptive immune response.  Viral infection to neutrophils may 
significantly affect their number (quantity) and functional activity.  This can lead to sub-
optimal innate immune defense as well as reduced stimulation to generate an effective 
adaptive immune response.   
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 To address these questions, the major objective of current study was to 
investigate the effect of different strains of BVDV on neutrophils.  Our hypotheses were: 
1) BVDV infection to neutrophils significantly affects neutrophil viability in a strain 
dependent manner; 2) BVDV infection changes the phenotypic characteristics of 
neutrophils; 3) BVDV infection alters the functional activity of neutrophils leading to 
immunomodulation. 
RESEARCH OBJECTIVES 
1) To isolate and culture bovine neutrophils as an in vitro model to determine effect of 
BVDV on innate immune system. With this objective, three approaches were taken: 
a) Optimize methods for neutrophil isolation from bovine peripheral blood to achieve 
high yields and viability.  
b) Optimize morphological and phenotypic characterization of the neutrophils. 
c) Optimize culture conditions for the neutrophils.  
2) Investigate the effect of BVDV on neutrophil viability and phenotype. The approaches 
for this objective were: 
a) Study the effect of different biotypes and virulent strains of BVDV on neutrophils 
viability as well as surface marker expression (CD14, CD18 and L-selectin). 
3) Investigate the effect of different strains of BVDV on neutrophil functional activity.  
Under this objective, four major functions of neutrophils were investigated: 
a) Phagocytic activity  
b) Chemotaxic ability  
c) Oxidative burst  
d) Neutrophil extracellular trap formation  
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LITERATURE REVIEW 
 
1.1 BVDV disease:  
 Bovine viral diarrhea virus (BVDV) is a major problem for the cattle industry 
worldwide.  BVDV infections cause multiple forms of disease ranging from inapparent to 
lethal mucosal disease (MD) (Chase et al. 2015).  Its ability to establish lifelong 
persistent infection in animals, rank this disease as the most insidious and devastating 
viral pathogen of the cattle industry (Brackenbury et al. 2003, Chase et al. 2004, Chase 
2013, Chase et al. 2015).  
  Despite 60 years of vaccination, BVDV infections remain a source of significant 
economic loss for producers in the United States (Van Campen 2010, Ridpath 2012) and 
the world (Houe 1999, Mockeliuniene et al. 2004).  The economic importance of BVDV 
increased with emergence of more virulent strains during early 1980s and 1990s (Goens 
2002).  A study conducted in 1999, estimated that farmers lose about US$20 million per 
million calvings when animals were infected with a low-virulence BVDV strain, however 
it increased to US$57 million per million calvings with a highly-virulent BVDV strain 
(Houe 1999).  The recent appearance of a new putative pestivirus species, tentatively 
called "HoBi-like" or "BVDV-3" or "atypical pestiviruses," which was first identified 
in Europe in a fetal bovine serum (FBS) imported from Brazil (Bauermann et al. 2013), 
may further increase these losses.  
 BVDV infections produce variable and complicated symptoms, that vary from 
growth retardation, persistent infection, hemorrhagic symptoms, respiratory and enteric 
infections, reproductive disease to lethal mucosal disease (MD) (Chase et al. 2015). On 
the basis of severity and duration, BVDV infection can be divided into various forms: 
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inapparent infections, acute disease, in utero or congenital infection, mucosal disease and 
chronic disease.  
 The inapparent form of disease is characterized by a slow rise in antibody levels over 
the first 10-12 weeks after infection and an inability to recover virus. The failure to 
isolate virus from either nasal swabs or blood and the slow development of detectable 
antibody in serum may be due to antibody is still developing and in an undetectable range 
and the virus may be sequestered in lymphoid tissues (Ohmann 1983).  
 Acute infection is most commonly caused by the noncytopathic (ncp) strain of 
BVDV (Lanyon et al. 2014), characterized by reduced general health condition, 
respiratory distress, increased body temperature, sporadic coughing, nasal discharge and 
elevated body temperature (Muller-Doblies, Arquint et al. 2004). Viremia can be 
observed as early as 2 days post infection and usually peaks at 7 days post infection 
(Smirnova et al. 2008), with the highest body temperature reaching values above 39°C. 
The rise in body temperature is generally biphasic, with one peak at day 4 and a second 
peak at day 8. These clinical signs last from 3 to 15 days with a full recovery by the end 
of three weeks (Muller-Doblies, et al. 2004). An acute infection has different outcomes 
depending upon physiological status of the infected animals (Figure 1.1).  
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Figure 1.1. Clinical forms of BVDV. BVDV can cause a spectrum of diseases depending 
on the virulence of the strain and the immune state of the host. Adapted from Elmowalid, 
G (2003). Unmasking the effect of bovine viral diarrhea virus on macrophage 
inflammation. Ph.D. Thesis. South Dakota State University, Brookings, SD 57007, U.S.A 
(Pt): 73 
 
 BVDV infection of pregnant animal results in a placentome infection, leading to an 
in utero or congenital infection. The in utero or congenital infection early in pregnancy 
generally results in early embryonic death and infertility (Van Oirschot 1983).  BVDV 
infection of pregnant cows significantly reduced conception rates (Virakul et al. 1988, 
McGowan et al. 1993) and resulted in death, abortion or mummification of the fetus 
(Kendrick 1971, Sprecher et al. 1991, Barr and Anderson 1993).  Fetal death during that 
period may be due to extensive damage of placenta that interferes with the oxygen and 
nutrient supply to fetus (Murray 1991).  However, experimental infections with the 
cytopathic (cp) strain at a similar stage of pregnancy did not affect conception or fetal 
viability, indicating the importance of different biotypes in disease outcomes (Brownlie et 
al. 1989).  
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 In addition to death, abortion or mummification of the fetus, BVDV infection to 
pregnant cows may result in birth of anatomically abnormal calves.  Congenial defects 
result when BVDV establishes a stable infection during early organogenesis in the 
developing fetus (Van Oirschot 1983, Karakaya et al. 2013, Brown et al. 1973, Done et 
al. 1980).   
 The most important fetal infection outcome is persistent infection (PI).  PI generally 
occurs in calves, which are infected with ncp BVDV during the first 40-120 days of 
pregnancy.  This occurs because the fetal immune system is not fully developed and 
cannot distinguish self and non-self-antigen (Brackenbury et al. 2003, Chase et al. 2004, 
Chase et al. 2015).   
 In PI, the BVDV infected animals immune system treat BVDV as self and are 
tolerazied. This results in the lack of a BVDV immune response including neutralizing 
antibody. PI animals may look apparently health but they serve as a continuous source of 
BVDV infection to other animals. In these PI animals, any stress may cause mutations in 
the ncp BVDV strain to become a homologous cp strain (Tautz et al. 1998, Darweesh et 
al. 2015) and the superinfection of antigenically homologous ncp and cp BVDV strain 
results in fatal mucosal disease (Brownlie et al. 1984, Sentsui et al. 2001, Kane et al. 
2015).  Mucosal disease is characterized by high mortality and extensive lesions in the 
gastrointestinal tract (Huck 1957).  
1.2 Bovine Viral Diarrhea Virus:  
Bovine viral diarrhea virus (BVDV) is a single-stranded, positive-sense RNA 
virus belonging to the Pestivirus genus and the family Flaviviridae (Ostachuk 2016). The 
virus shares similarities to other genera of Flaviviridae, which includes viruses of human 
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importance including hepatitis C virus, yellow fever virus, Dengue fever virus, Japanese 
encephalitis virus, West Nile virus, St. Louis encephalitis virus and the recently 
reemerging Zika virus (Burd and Griffin 2016). The Pestivus genus also contains two 
other viruses of animal importance: classic swine fever virus and border disease virus in 
sheep (Nettleton et al. 1998). 
  BVDV has a genome of approximately 12.5 kb that encodes a single open reading 
frame. This single open reading frame encodes a polyprotein of about 4000 amino acids. 
This polyprotein is then cleaved into 11-12 individual viral proteins either by host cell 
and/or viral proteases (Tautz et al. 1996, Xie et al. 2014) to make the complete virion.  
(Figure 1.2). 
 
 
 
Figure 1.2. The schematic representation of the BVDV encoded proteins. BVDV is a 
single-stranded RNA virus comprised of 12,300 nucleotides. BVDV consists of a single 
open reading frame between two untranslated regions (5’ and 3’). The polyprotein is 
autoprocessed into both structural and non-structural proteins. In cytopathic biotype 
viruses, NS23 protein cleaves into NS2 and NS3 proteins (CP-lower panel) while in 
noncytopathic biotype viruses, NS23 does not cleave into two proteins (NCP upper 
panel). from:  Morarie, S.E. (2012). “Unraveling the biology of bovine viral diarrhea 
virus (BVDV) persistent infections: integrating field and laboratory studies.” Ph.D. 
Thesis. South Dakota State University, Brookings, SD 57007, U.S.A (Pt): 9. 
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BVDV strains can be classified in two ways: 1) comparison of sequences from the 
5' untranslated region (UTR) of the viral genome, which divide BVDV into two 
genotypes  Type 1 (BVDV1) or Type 2 (BVDV2) and subgenotypes,1a, 2a, etc. (Ridpath 
et al. 1994) and 2) their cytopathogenicity in cell culture-where BVDV is divided into 
two biotypes; cytopathic (cp) or non-cytopathic (ncp) BVDV (Weiss et al. 1994, Deregt 
and Loewen 1995).   
The phylogenetic analyses of BVDV isolates using the least conserved portion of 
the BVDV E2 glycoprotein gene (sequence of 420 nucleotides) also can be used to 
identify the two genotypes (BVDV1 and BVDV2) classification based on 5' UTR 
sequence (Tajima and Dubovi 2005).  At the time of this writing, the BVDV1 genotype 
has at least 15 subtypes (1a-1o) with complete genomic sequences of subtype BVDV-1a, 
1b, 1d, 1e, 1k and 1m while BVDV2 genotype has only two subtypes, BVDV2a and 2b 
(Xie et al. 2014). 
The cp biotypes of BVDV are generated by mutation with a few nucleotides 
inserted in their homologous ncp biotypes, that results in nonstructural protein NS23 
being cleaved into NS2 and NS3 (Tautz et al. 1996, Balint et al. 2005, Darweesh,  et al. 
2015) (Figure 1.2)  
1.3 Structure of BVDV virion and its replication:  
BVDV is a relatively small oval to pleomorphic enveloped viral particle, 40-60 
nm in diameter, with numerous projecting knobs, 4 to 5 nm in diameter in its envelope 
(Chu and Zee 1984, Ohmann 1990). BVDV genome (12.5 kb) is packed with C (capsid) 
protein and finally by envelope glycoproteins Erns, E1 and E2. E2 (Wang et al. 2014).  
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The binding of glycoproteins with various cell surface receptors including cluster 
of differentiation 46 (CD46), heparan sulfate, glycosaminoglycans and/or the low-density 
lipoprotein (LDL) receptor help virus attachment to host cell (Iqbal et al. 2000, Krey et 
al. 2006, Krey et al. 2006) followed by clathrin-dependent endocytosis (Krey et al. 2006). 
The low pH of the endosomes in the cytoplasm induces fusion of viral and endosomal 
membrane, causing release of the genome.  
Viral RNA replicates and is translated into structural and non-structural proteins. 
The virions assemble in association with the endoplasmic membrane (Jordan et al. 2002) 
and autophagosomes (Ohmann 1990, Fu et al. 2014, Rajput, 2013) and are subsequently 
released either by cell lyses and/or via exocytosis. (Figure 1.3) 
 
Figure 1.3. BVDV replication cycle. BVDV virion binds to specific cellular receptors: 
cluster of differentiation 46 (CD46), heparan sulfate, glycosaminoglycans and/or the 
low-density lipoprotein (LDL) receptor through their envelope proteins. Following 
attachment, BVDV virion are internalized through receptor-mediated endocytosis. The 
virion replicates in the cytoplasm and assembles in the endoplasmic reticulum. Mature 
BVDV virions are released through virion-containing vesicles that fusion to the host cell 
plasma membrane. Adopted from Lindenbach and Rice, 2001. Flaviviridae: the viruses 
and their replication, In: Knipe, D.M., Howley, P.M., Griffin, D.E., Lamb, R.A., Martin, 
M.A., Roizman, B. (Eds.), Fields Virology, 4th ed., Vol. 1. Lippincott Williams & Wilkins, 
Philadelphia, PA, pp. 991–1041. 
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During replication, the BVDV polyprotein is cleaved into 11-12 individual viral 
proteins: Npro, capsid/nucleocapsid (C), Erns, envelop 1 (E1), E2, P7, non-structural 23 
(NS23) [NS2 and NS3 in cp BVDV], NS4A, NS4B, NS5A and NS5B, respectively by 
host cell and viral proteases. The processing of the polyprotein starts with cleavage of 
nucleocapsid protein (C) by Npro, which contains autoprotease activity (Rumenapf et al. 
1993, Stark et al. 1993).  
This event is followed by cleavage of Erns12 protein at the C terminus of E2 
protein separated from Erns12, resulting Erns1 and E2 proteins. After E2 (gp53) is 
released from the precursor, E01 is processed into Erns (gp48), E1 (gp25) by 
endoplasmic reticulum (ER)-resident host cell proteases (Rumenapf et al. 1993, Bintintan 
and Meyers, 2010). 
A protease located in the N-terminal region of nonstructural (NS) protein, NS3, 
catalyzes the cleavages and release of NS4A, NS4B, NS5A, and NS5B (Tautz et al. 
2000). Each processed protein in BVDV has its unique role in virus replication. The C 
protein play an important role in genomic RNA packaging (Reimann  et al. 2007) and 
provides structure for the virion envelope. The Erns, E1, and E2 have important roles in 
virus binding and cell entry as well as for immunologic recognition by the host.  
The E2 protein contains the major recognition sites for BVDV neutralizing 
antibodies. The neutralizing epitopes of E2 are important targets for BVDV vaccine 
efficacy (Donofrio et al. 2006, Chimeno Zoth et al. 2007). Unlike E1 and E2, Erns is 
dispensable for cellular entry (Iqbal et al. 2004, Ronecker et al. 2008). The E1 protein is 
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predicted to have various functions including a membrane anchor for E2. The E1 and E2 
form E1-E2 heterodimers. 
The E1-E2 heterodimers appear to be essential for cell entry of BVDV (Ronecker 
et al. 2008).  Among the BVDV nonstructural proteins, the Npro (p20) is the first protein 
produced from the open reading frame. It has papain-like protease activities (Rumenapf 
et al. 1998), which initiates BVDV polyprotein processing (Stark et al. 1993). NS23 
(p125) mediates multiple functions including zinc-finger, a protease, and a helicase 
(Wiskerchen and Collett 1991, Warrener and Collett 1995, Xu et al. 1997). However, for 
full serine protease activity, NS3 requires NS4A (p10) as a cofactor (Lattwein  et al. 
2012). The cleavage of NS23 protein in NS2 (p54) and NS3 (p80) results in cytopathic 
BVDV strains (Balint et al. 2005, Darweesh et al. 2015). Protease activity of NS3 cleaves 
NS4A, NS4B (p32), NS5A (p58) and NS5B (p75). 
The NS4B protein plays an important role in the BVDV replication complex 
(Weiskircher et al. 2009), while NS5A contains an essential zinc-binding site 
(Tellinghuisen et al. 2006). The NS5B (p75) acts as RNA-dependent-RNA polymerase 
and is needed to replicate the viral genome (Zhong et al. 1998). 
1.4 BVDV- induced Immunosuppression:  
BVDV infection is an immunosuppressive infection. It affects both the adaptive 
as well as the innate immune system (Chase 2013). BVDV infection reduced the number 
and functional ability of both granulocytes as well as monocytes (Brewoo et al. 2007). An 
acute BVDV infection or vaccination with modified live virus vaccine (MLV) of BVDV 
resulted in decreased delayed type hypersensitivity (DTH) to Mycobacterium avium 
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subspecies (Thoen and Waite 1990). Similarly, animals with an established immune 
response to attenuated  
Mycobacterium bovis (BCG) had a transient immune suppression following acute ncp 
BVDV infection (Charleston et al. 2001). Immunosuppression caused by BVDV 
facilitated secondary infections from bovine respiratory syncytial virus, parainfluenza 
virus, reovirus, bovine adenovirus and bovine herpesvirus-1 infection (Richer et al. 1988, 
Risalde et al. 2011). 
BVDV is an important part of the bovine respiratory disease complex (BRDC) 
(Hay et al. 2016).  BRDC is one of the most economically significant disease of the cattle 
feedlot industry (Larson 2015), which further enhances the economic impact of BVDV in 
a country’s agricultural economy 
1.4.1 Effect of BVDV on Innate immune response: 
The pattern recognition receptors (PRR) including Toll-like receptors (TLR), 
retinoic acid-inducible gene-I-like receptors (RIG-I-like receptor) and nucleotide-binding 
oligomerization domain-like receptors (NOD like receptors) play an important role in 
innate immune system. These receptors activate the innate immune system and shapes an 
effective adaptive immune response (Kawai and Akira 2009, Kumar et al. 2011).  
The interaction of TLR with their respective ligands leads to downstream pathway 
changes to cytokines and chemokines (Schaefer et al. 2004). Both cp and ncp BVDV 
altered the TLR3, TLR7, TLR8 and TLR9 expression (Lee et al. 2008).  Both biotypes 
upregulated TLR7 expression while, only ncp BVDV enhanced the expression of 
TLR3,while TLR3 was down regulated by cp BVDV.  In addition, both these laboratory 
biotypes suppressed pro-inflammatory cytokines, TNF-alpha, IL-1beta, IL-6 and co-
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stimulatory molecules, CD80 and CD86, following infection (Lee et al. 2008). More 
virulent NCP strains enhance pro-inflammatory cytokines (Chase personal 
communication).  Ncp BVDV did not induce type 1 interferons in vitro (Diderholm and 
Dinter 1966).  However, a strong type 1 interferon response was observed in an in vivo 
experiment with similar ncp strain (Charleston et al. 2002), indicating that BVDV 
biotypes behave differently in different environments.  
Ncp BVDV infection  reduced IFNγ and IL-12 production (Risalde et al. 2011). 
IL-12 acts as a growth factor for NK cells and cytotoxic T cells (Trinchieri 1995), 
indicating that BVDV infection can indirectly affect NK cells and T cells activity through 
IL-12. In addition to cytokines, various antimicrobial peptides and superoxides also 
modulate the innate immune response (Ganz 2003, Break et al. 2012). Both cp TGAC 
and ncp TGAN BVDV reduced phorbol-12-myristate-13 acetate (PMA)-induced 
superoxide production following infection, while only ncp BVDV primed bone marrow-
derived macrophages (BBMM) enhanced reactive nitrogen production in response to 
Salmonella dublin (Adler et al. 1994). Similarly, only BVDV2, not BVDV1 inhibited the 
LPS-induced upregulation of tracheal antimicrobial peptide (TAP) mRNA (Al-Haddawi 
et al. 2007). Another study showed that BVDV (unidentified strain) inhibited 
phytohemagglutinin- (PHA), PHA plus phorbol-12-myristate-13 acetate- (PMA) or PHA 
plus calcium ionophore (A23187)-stimulated bovine peripheral blood mononuclear cell 
(PBMC) proliferation.  Further, BVDV inhibited A23187stimulated leukotriene B4 
(LTB4) synthesis in the culture supernatants (Atluru et al. 1992). 
1.4.2 BVDV, neutrophils and immune response: 
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Neutrophils are one of the predominant white blood cells in circulating blood and 
are considered the first line of defense in the innate immune system (Kobayashi and 
DeLeo 2009) along with macrophages. Neutrophils play an important role against 
invading bacteria and, initiate innate as well as adaptive immune responses. Neutrophils 
activate innate immune response through various mediators including interleukin-8 (IL-
8), platelet activating factor (PAF), leukotriene B4 (LTB4) or complement fragment 5a 
(C5a) (Guo et al. 2003, Mitchell et al. 2003, Mantovani et al. 2011, Mitchell et al. 2014). 
The ability of neutrophils to migrate and destroy the invading microorganism depends 
upon their expression of surface markers including  cluster of differentiation (CD) -14 
(CD14), CD-18 and L-selectin (Yoshitake et al. 2002) Virus affecting the neutrophil 
surface markers can significantly affect the host immune defense mechanism.  
Normally, neutrophils are present in circulation in a resting state, which ensures 
that their oxidative intracellular contents are not released to damage the host tissue 
(Wright et al. 2010). During acute inflammation, neutrophils become activated and kill 
the invading organism (mainly bacteria) and help in shaping adaptive immune response 
(Kasama et al. 2005, Jaillon et al. 2013). Neutrophils activate the adaptive immune 
system through pro-inflammatory cytokines and chemokines including tumor necrosis 
factor alpha (TNF α), interleukin-1β (IL-1β), interleukin-8 (IL-8), interleukin-6 (IL-6), 
interferon inducible protein 10 (IP-10) and macrophage inflammatory protein (MIP)-1α 
(Altstaedt et al. 1996, Kasama et al. 2005).  
Neutrophils become activated via a two-stage process: 1) priming and 2) 
mobilization. Priming occurs by exposure to invading bacterial products or the 
cytokines/chemokines, TNF-α, GM-CSF, IL-8, IFN-γ, and /or MIP-1 (Hallett and Lloyds 
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1995, Mercer-Jones et al. 1999). This rapid priming occurs within minutes after receiving 
the signals. The primed neutrophils have an extended life span. Activated neutrophils are 
mobilized to the site of infection by chemoattractants N-formylmethionyl-leucyl-
phenylalanine (fMLP) or complement component 5a (C5a). These chemoattractants 
induce cellular polarization to make actin-rich pseudopodia, which helps in their 
movement (Servant et al. 2000).  
Formation of pseudopodia also helps in phagocytosis and destroying invading 
bacteria through intracellular phagosome and reactive oxygen species (ROS) (Lee et al. 
2003). In addition to these strategies, neutrophils also use neutrophil extracellular traps 
(NET) to destroy larger pathogens which cannot be phagocytized (Segal 2005, Halverson 
et al. 2015). The process of NET formation is NETosis. NETosis is distinct from 
apoptosis and necrosis and defined as the release of nuclear DNA, DNA associated 
proteins and lactate dehydrogenase (LDH) from an activated neutrophil into the 
extracellular environment (Kawasaki and Iwamuro 2008, Urban et al. 2009, Brinkmann 
and Zychlinsky 2012). NET also contains primary, secondary, and tertiary granular 
components that include neutrophil elastase, cathepsin G, and myeloperoxidase (MPO) 
(Urban et al. 2009, Brinkmann and Zychlinsky 2012), lactoferrin, and gelatinase 
(Borregaard 2010).  Among all the components, histones proteins are the most abundant 
component and act as a potent antimicrobial agent (Kawasaki and Iwamuro 2008, Urban 
et al. 2009).  
During NET formation, the nuclear envelope degrades and the mixing of nuclear 
DNA with cytosolic proteins takes place, which then extrude from the cell to trap the 
invading pathogen. NET can be induced by the treatment of neutrophils with interleukin-
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8 (IL-8), phorbol 12-myristate 13-acetate (PMA), lipopolysaccharide (LPS), bacteria, 
fungi or activated platelets There are number of viruses which also induce the NET 
formation including influenza A virus, HIV-1 virus, myxoma virus, 
encephalomyocarditis virus and respiratory syncytial virus (Narasaraju et al. 2011, Saitoh 
et al. 2012, Jenne et al. 2013, Funchal et al. 2015). There is no information on the  effect  
of BVDV on neutrophil NET formation. There are few studies on the effect of  BVDV on 
neutrophils.  Most of the information is from histological examination  characterizing 
BVDV lesions or through immunocytochemical/flow cytometric procedures (Bolin and 
Ridpath 1990) characterizing population dynamics but only a few studies have looked at 
the effect of BVDV on neutrophil function. BVDV infection significantly reduced the 
number of circulating neutrophils (Roth et al. 1981, Brown et al. 1991, Ganheim et al. 
2005) with reduced degranulation and impaired myeloperoxidase, hydrogen peroxide, 
halide antibacterial activity (Roth et al. 1981). Similarly, vaccination with BVDV 
modified live virus vaccine (MLV) significantly reduced circulating neutrophils, 
suppressed iodination, and antibody-dependent cell-mediated cytotoxicity (ADCC) 
activity (Roth and Kaeberle 1983).  High (HV24515) and low virulent (LV11Q) ncp 
BVDV-2 infection induced a severe neutropenia after viral inoculation. The number of 
neutrophils returned to normal but recovery was delayed in calves infected with high 
virulence virus as compared to low virulence (Keller et al. 2006).  
Several studies have been done to study the effect of BVDV on chemokines (Burr 
et al. 2012) and pro-inflammatory cytokines (Schweizer and Peterhans 2001, 
Fredericksen et al. 2015).   IL-1β, IL-8, IL-15, IL-18, Mx-1, IFN gamma, which recruit or 
activate neutrophils, have all been studied (Hammond et al. 1995, Leung et al. 2001, 
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Verri et al. 2007). However, a study to determine the effect of BVDV on neutrophil 
function with its underline mechanism is needed.  
The current study was designed to understand the effect of BVDV infection on 
neutrophil phenotype as well as functional activities of migration/chemotaxis, 
phagocytosis, oxidative burst and NETs formation. There are over 200 identified strains 
of BVDV that are either type 1 or type 2 genotype, or cp or ncp biotypes. The current 
study used BVDV strains from both genotypes as well as biotypes to study their effect on 
neutrophils. The BVDV strains used in current study were a virus pair (biotypes) of cp 
BVDV1b TGAC and ncp BVDV1b TGAN from type 1a genotypes and a highly 
pathogenic ncp BVDV2a 1373 and moderate pathogenic ncp BVDV2a 28508 type 2a 
genotypes.  
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CHAPTER 2 
EFFECT OF BVDV ON VIABILITY OF BOVINE NEUTROPHILS AND ITS CELL 
SURFACE MARKERS EXPRESSION  
 
ABSTRACT 
Infection with bovine viral diarrhea virus (BVDV) is one of the most important 
infectious causes of immunosuppressive in ruminants. One of the hallmarks of 
immunosuppression is reduced cell surface markers expression on antigen presenting 
cells.  However, very little known is about the effect of BVDV infection on neutrophil 
viability and surface marker expression. In this chapter, the effect of BVDV infection on 
viability of neutrophil and surface marker expression of  cluster of differentiation -14 
(CD14), CD-18 and L-selectin were examined. Bovine neutrophils were isolated by 
gradient centrifugation followed by red blood cells (RBCs) lysis and neutrophil 
restoration. Isolated neutrophils were confirmed morphologically and phenotypically and, 
further examined for viability, purity and yield.  The neutrophils had characteristic 
polymorphic nucleus with 99.80±0.1% purity and 98.86±0.90 % viability. Isolated 
neutrophils had high expression for CD18+ (99.77±0.13%) and L-selectin (97.05±2.41%) 
and low CD14+ (11.34±3.89%) expression. The typical yield was 20.64±1.89 106 
neutrophils from 50 ml of peripheral blood (e.g. A 10 ml cell suspension with 
concentration of 2.064±1.89x106/ ml was obtained from 50 ml blood) 
To determine the effect of BVDV biotype on neutrophil viability and phenotypes, 
neutrophils were infected with either Tifton Georgia cytopathic (TGAC) or Tifton 
Georgia noncytopathic (TGAN) strains recovered from an animal that died of mucosal 
disease. Neither of the biotypes (TGAC or TGAN) used in the study affected the viability 
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of neutrophils in vitro.  Interestingly TGAC and TGAN reduced the expression of CD18 
and L-selectin while increasing CD14 expression. This effect on surface marker 
expression by TGAC or TGAN infection likely reduces neutrophil migration and 
extravasation.  
 
INTRODUCTION 
Bovine viral diarrhea virus (BVDV) is one of the most insidious and devastating 
viral pathogens of the cattle industry around the world (Ridpath, 2012; Van Campen, 
2010). The main hurdle in BVDV control is immunosuppression, which reduces vaccine 
efficacy and places animals in a greater risk of secondary infections (Hay et al., 2016; 
Richer et al., 1988; Risalde et al., 2011).  Several studies have demonstrated the effect of 
BVDV on immune cells that influence adaptive immune system including monocytes 
(Glew et al., 2003), macrophages (Chase et al., 2004), dendritic cells (Glew et al., 2003; 
Rajput et al., 2014) and lymphocytes (Rypula, 2003). However, very little is known about 
the effect of BVDV on the granulocytic cells of the innate immune system. Neutrophils 
are the one of the predominant white blood cells and considered a first line of defense in 
the innate immune system (Kobayashi and DeLeo, 2009). Neutrophils play an important 
role against invading bacteria and help initiate the adaptive immune response.  
Neutrophils phagocytize invading microorganisms and activate innate as well as adaptive 
immune response through various mediators including interleukin-8 (IL-8), platelet 
activating factor (PAF), leukotriene B4 (LTB4) or complement fragment 5a (C5a) (Guo et 
al., 2003; Mantovani et al., 2011; Mitchell et al., 2003; Mitchell et al., 2014). However, 
the functional ability of neutrophils is dependent on its cell surface maker expression of 
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CD14, CD-18 and L-selectin. CD14 helps in bacterial recognition (McAvoy et al., 2011), 
while CD18 and L-selectin helps in migration (receptor mediated homing) (Gao and 
Issekutz, 1996; Gomez and Doerschuk, 2010) as well as in adhesion (von Andrian et al., 
1993) respectively.  Finally, those surface markers help in activating the neutrophils. 
Activated neutrophils not only destroy the invading pathogens but also activate the 
adaptive immune system (Jaillon et al., 2013). 
In the current study, we optimized a simple, reproducible method to isolate bovine 
neutrophils with high purity, yield and viability. Isolated neutrophils were confirmed 
morphologically as well as phenotypically. Freshly isolated neutrophils were used to 
measure the effect of BVDV biotypes on viability and surface marker expression (CD14, 
CD18 and L-selectin). 
MATERIALS AND METHODS 
Cell and Virus Strains and Virus Propagation 
A homologous pair of ncp and cp type 1b viruses, Tifton GeorgiA Non-cytopathic 
(ncp BVDV1b TGAN) and Tifton GeorgiA Cytopathic (cp BVDV1b TGAC) were 
isolated from an animal that died of mucosal disease (Brownlie et al., 1984; Ridpath et 
al., 1991) were used.  Virus stocks of each BVDV strain was prepared in BVDV-free 
Madin Darby bovine kidney (MDBK) cells. BVDV-free MDBK cells (passages 98-112) 
were grown in minimal essential medium (MEM, Gibco BRL, Grand Island, NY) (pH 7-
7.4) supplemented with 10% BVDV-free fetal calf serum (FCS) (PPA, Pasching, 
Austria), penicillin (100 U /ml) and streptomycin (100 μg /ml).  A five (5) ml of 5x105 
MDBK cells/ml were seeded in T25 flasks using minimal essential medium (MEM, 
Gibco BRL, Grand Island, NY) supplemented with 10% FBS, penicillin (100 U/ml) and 
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streptomycin (100μg/ml) (Sigma-Aldrich, St. Louis, MO, USA). Cells were grown to 60-
70% confluency and infected with either of each virus.  At the time of infection, the 
media was removed from T25 flasks and 0.75 ml of virus inoculum with a multiplicity of 
infection [MOI] of one was added to each flask. Virus was adsorbed for 1 hr at 37°C in a 
humidified CO2 incubator with gentle rotation at every 15 minutes. After one hr 
incubation, unabsorbed virus was removed and the cells were washed with sterile PBS. 
After washing, 5 ml MEM medium supplemented with 10% FBS, penicillin (100 U/ml) 
and streptomycin (100μg/ml) was added to each flask. The cells were incubated at 37°C 
in a humidified CO2 incubator for 4-5 days or up to 70-80% cytopathic effect for cp 
BVDV1b TGAC. After 4-5 days of incubation, cells were frozen at (-80˚C for 15 
minutes) and thawed in ice for two cycles. The cell debris were pelleted by centrifugation 
at 3000 rpm for 10 min at 4°C in 15 ml conical tubes. The supernatants, containing virus 
were carefully collected. Supernatants were titrated for virus concentration and then 
aliquoted and stored at -80 °C for further use.  
The viral titers were determined by serially inoculating 1:10 dilutions of 
supernatants on MDBK cells as per method described earlier (Reed and Muench, 1938). 
Briefly MDBK cells were detached from tissue culture flask using 0.25% trypsin-EDTA 
(Sigma-Aldrich, St. Louis, MO, USA). The number of cells was adjusted to 5x105 cells/ 
ml.  One hundred eighty (180) µl cell suspension was added to each well of 96-well plate. 
Twenty (20) µl of virus was added to the first row of the plate. The virus was then mixed 
with MDBK cells and 20 µl of this dilution was added to next row to achieve 10-fold 
dilutions.  The last two rows were treated as negative controls with no virus. The plates 
were incubated at 37°C in humidified incubator for next 4 days. The plate was examined 
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every day for cytopathic effect (CPE). The highest dilution showing CPE was used as end 
to calculate the proportionate distance (PD). The PD was then used to determine the viral 
concentration (TCID50) as per formula as described earlier (Reed and Muench, 1938). 
 
1. Proportionate distance (PD) = (% CPE at dilution above 50%) – (50%)/ (% CPE 
at dilution above 50%)- (% CPE at dilution below 50%) (e.g.  60-50/60-0= 0.166) 
2. Calculation of endpoint just next to 50% CPE and conversion into – Log (e.g.10-6 
dilution would be -6) 
3. Calculation of TCID50.  
4.  TCID50 for 20 µl= (PD+ - Log dilution above 50%) (e.g. 1x106.166) 
For ncp BVDV, the same procedures were done except the endpoint for ncp 
BVDV was determined by staining the MDBK cells with anti-BVDV antibody (IDEXX 
Laboratories, Westbrook, ME, USA) followed by biotinylated rabbit anti-mouse IgG 
(Zymed, Invitrogen Corporation, Frederick, MD, USA), streptavidin-HRP (Invitrogen 
Corporation, Camarillo, CA, USA) and AEC reagent (3 amino-9 ethyl-carbazole) 
(Sigma-Aldrich, St. Louis, MO, USA). The endpoint for ncp BVDV was determined by 
the presence of red stained cells showing BVDV protein.  
Animals 
Sixteen (16) healthy cattle including Holstein Friesian (n=9) and Brown Swiss calves 
(n=7) (8-12 months of age), housed at the Department of Dairy Science Dairy Farm, 
South Dakota State University (SDSU), Brookings, SD, USA were used in this study. 
The SDSU Institutional Animal Care and Use Committee approved animal handling and 
blood collection. 
Neutrophil Isolation and Viability 
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To isolate neutrophils, fifty (50) ml of peripheral blood was collected in 10 ml 
heparinized vacutainer tubes (BD, Franklin Lakes, New Jersey, USA). The neutrophils 
along with red blood cells (RBCs) were separated by centrifuging the blood at 1,000 X g 
for 30 minutes at 25°C. The plasma and buffy coat were removed and discarded.  The 3-
ml cell pellet (neutrophils+ RBCs) was divided among eight (8), 15 mL conical tubes. To 
each 15-mL conical tube, 10 mL of RBC lysing solution was added. Each tube was 
gently inverted several times for 10 minutes to lyse the RBCs. After gently inverting the 
tubes, the tubes were centrifuged at 1,000 X g for 5 minutes at 25°C. Supernatants were 
discarded and cells pellets were washed 3 times using 10 mL of HBSS (the tubes were 
centrifuged at 1,000 X g for 5 minutes at 25°C). After each wash, cell pellets from two 
tubes were combined to one, leaving 4 tubes, 2 tubes and 1 tube at the end of each wash 
(after three wash, cells from eight tubes were combined to one tube). The final cell pellet 
was suspended in 10 mL RPMI 1640 medium (MEM, Gibco BRL, Grand Island, NY) 
supplemented with 10% BVDV-free fetal calf serum (FCS) (PPA, Pasching, Austria), 
sodium pyruvate, penicillin (100 U/ml) and streptomycin (100μg/ml) (Sigma-Aldrich, St. 
Louis, MO, USA). Freshly collected neutrophils were examined for purity through 
morphological examination using 4',6-diamidino-2-phenylindole (DAPI) as well as 
hematoxylin and eosin (H & E) staining as described below. 
Freshly collected neutrophils were also examined for yield. Neutrophil yield was 
calculated using trypan blue staining as described above. The total number of 
neutrophil/mL was measured using a hemocytometer.  The calculation was multiplied by 
diluting factors (eg. 100) and total number of cells calculated using the following 
formula. 
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Total neutrophil yield (from 50 mL blood)= Total number of cells calculated through 
hemocytometer/mL X dilution factor (eg. 
100) X Total volume of cells (eg. 10 mL).   
The typical yield from 50 ml of peripheral blood was 20.64±1.89x106 neutrophils 
(e.g. A 10 ml cell suspension with concentration of 2.064±1.89x106/ ml was obtained 
from 50 ml blood) 
Neutrophil viability was examined through trypan blue exclusion assay as well as 
by apoptosis using Annexin V Apoptosis Detection Kit (eBiosciences, San Diego, CA).  
The trypan blue exclusion assay was used to determine the cell viability by staining the 
neutrophils with 0.4% trypan blue stain as described (Strober, 2001).  Briefly, in 20 µl 
freshly isolated neutrophils suspension [after 1:100 dilution in 1x phosphate buffered 
saline (PBS)] was mixed with 20 µl of 0.4% trypan blue. The cells were incubated for 2 
minutes at room temperature and examined under microscope. The non-stained viable 
cells were counted and cell viability was calculated using the following formula. 
Cell viability percentage = Number of viable cells (none trypan blue stained cells) 
cells X   100/Total counted cells. 
 
Freshly collected neutrophils were also examined for apoptosis using Annexin V 
Apoptosis Detection Kit (eBiosciences, San Diego, CA). Briefly, 50 ul neutrophils (a 
1.0x106 neutrophils in 50 ul) were suspended in equal volume of 1X Binding Buffer 
[(BB) provided with the Kit]. One hundred (100µl) of suspended-1X BB neutrophils 
were then added to each round bottom 96 well plates in triplicates. Five microliters (5 μl) 
of fluorochrome-conjugated Annexin V (provided with Kit) was added to each well and 
45 
 
the plates were incubated for 10-15 minutes at room temperature in the dark. Cells were 
washed with 1X 200 μl binding buffer by centrifugation at 200xg for 4 minutes at room 
temperature and analyzed by flow cytometry using a FACScan (Becton-Dickson, 
Mountain View, CA).  
To determine the effect of BVDV biotypes on neutrophil viability, neutrophils 
were infected with either cp BVDV1b TGAC or ncp BVDV1n TGAN at a MOI 6 for 0 
hr, 1 hr or 6 hr while mock-infected or LPS-treated (10 ng/ml) neutrophils were used as 
negative or positive controls respectively. Neutrophil viability was examined through 
trypan blue exclusion assay and Annexin V Apoptosis Detection Kit (eBiosciences, San 
Diego, CA) as described above. For apoptosis, 10µl. staurosporine (STS) was used as a 
positive apoptotic control in respective wells (Belmokhtar et al., 2001). 
 
Characterization of neutrophils 
Morphological characterization 
The freshly collected neutrophils were stained with 4’, 6-diamidino-2-
phenylindole (DAPI) (Chazotte, 2011) or H&E stain as per method described earlier 
(Bleyer et al., 2016). Neutrophils were cytospun at 1000x for 10 minutes at room 
temperature. After cytospinning, cells were either stained directly with DAPI stain or 
fixed with methanol for H&E staining. For H&E staining, fixed cells were immersed in 
hematoxylin stain for 10 seconds followed by washing with tap water. During washing, 
slides were immersed in water until slides were clear of stain. The slides were then 
immersed in eosin dye for 30 seconds followed by washing with tap water. Finally, H&E 
slides were air dried and examined under compound microscope at 20x (Olympus, PA, 
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USA) while the DAPI-stained cells were examined under florescent microscope with 
358⁄461nm excitation⁄emission filter at 20x (Olympus, PA, USA). 
 Phenotypic characterization using flow cytometry. 
 The phenotypic characterization of freshly collected neutrophils as well as 
neutrophils after BVDV infection was done by measuring CD14, CD18 or L-selectin 
surface marker expression. Briefly, freshly isolated neutrophils were collected by gentle 
pipetting and centrifugation for 5 min at 1500 rpm at room temperature. Cell numbers 
were adjusted to 1x106/ml in PBS containing 1% FBS. A 100 µl cell suspension were 
added to each well of round bottom 96-well plates in triplicate. Fifty (50) µl of primary 
antibodies of anti-CD14 antibody (clone M-M9), VMRD Inc, Pullman, WA.; anti-CD18 
antibody (clone BAQ30A; Kingfisher Biotechnology, St Paul, MN) or anti-L selectin 
antibody (clone FMC46; Novus Biological, Littleton, CO) were added to respective 
wells. The primary antibodies used in staining were pre-diluted 1:100 in PBS containing 
1% FBS.  After adding primary antibodies, cells were incubated at 4°C for 10 min 
followed by 2X washes with 200 µl PBS containing 1% FBS.  After washing, cells were 
stained with FITC-labeled anti-mouse secondary antibody (VMRD Inc., Pullman, WA, 
USA) with 1:1000 dilution in PBS containing 1% FBS at 4°C for 10 min.  After 
secondary antibody straining, cells were washed again for 2X as described above. 
Finally, stained cells were fixed with 200 µl of 1% paraformaldehyde and analyzed by 
FACScan (Becton-Dickson, Mountain View, CA). 
Virus infection of neutrophils 
Freshly collected neutrophils were suspended in RPMI 1640 medium 
supplemented with 10% FBS, penicillin (100 U /ml) and streptomycin (100 μg /ml) to 
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achieve final concentration 1x106 /ml.  One (1) ml of the cell suspension was added to 
each well of the 12-well plates. Cells were infected with either cp TGAC or ncp TGAN 
strains of BVDV with a multiplicity of infection (MOI) of 6.  Mock-infected neutrophils 
or lipopolysaccharide-treated (LPS; 10 ng/ml, Sigma-Aldrich, St. Louis, MO, USA) 
neutrophils were used as negative or positive controls respectively.  BVDV-, mock-
infected or LPS-treated neutrophils were collected at 0 hr, 1 hr or 6 hr, post infection 
(p.i.) and examined for their viability and cell surface marker expression of CD14, CD18 
or L-selectin as described above. These time points were chosen because beyond 6 hr, the 
short half of neutrophils resulted in high back ground apoptosis in the mock-infected cells 
so differences could not be measured. 
Statistical analysis 
The significance of BVDV infection on neutrophil viability and cell surface 
marker expression was calculated by paired t-test (Glantz, 2002).   
RESULTS 
Neutrophil morphology, viability and yield 
The isolated neutrophils had characteristic polymorphic nucleus (Figure 2.1), with 
99.80±0.1% purity.  H & E staining of neutrophils showed purple colored multiple 
lobulated nucleus (polymorphic nucleus) (Figure 2.1A). Similar multiple lobulated nuclei 
(polymorphic nucleus) were observed following DAPI staining (Figure 2.1B).  
Neutrophil purity was determined and confirmed through morphological examination, 
and differential leukocyte count (Chung et al., 2005) by the Veterinary Clinical Pathology 
Section, Animal Disease Research and Diagnostic Laboratory (ADRDL), South Dakota 
State University (SDSU), Brookings, SD.  
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Isolated neutrophil viability was 98.86±0.90% as measured by the trypan blue 
exclusion assay. The yield of was 20.64±1.89X106 neutrophils from 50 mL of peripheral 
blood.   
Phenotypic characterization of neutrophils  
Freshly isolated neutrophils were stained for CD14, CD18 or L-selectin.  Freshly 
isolated neutrophils were low in CD14+ (11.34±3.89), and high for CD18+ (99.77±0.13) 
and L-selectin (97.05±2.41) (Figure 2.2). 
The effect of BVDV infection on neutrophil viability  
Neutrophil viability did not change during BVDV infection (p<0.05). Neutrophil 
viability was 99.17± 1.41%, 98.13± 2.65% in unstimulated control cell while LPS-treated 
neutrophils was 98.25± 1.82% and 93.43± 3.08%, TGAC- and TGAN-infected neutrophil 
viability was 98.08± 1.26%, 97.33± 2.08% and 99.25±1.27%, 97.10± 1.09% at 1hr or 6 
hr post infection respectively, which were not significantly different from the 
unstimulated control cells (p<0.05) (Figure 2.3, Table 2.1).  
The effect of BVDV infection on neutrophil apoptosis was determined.   TGAN 
induced significant apoptosis at 1 hr post infection as compared to unstimulated control 
neutrophils (p<0.05).  At 1 and 6 hr post infection, TGAN induced around 7% and 1% 
higher apoptosis as compared to time point unstimulated control neutrophils respectively 
(Figure 2.4, Table 2.2).  TGAC induced approximately 3% and 4% more apoptosis at 1 
and 6 hr post infection as compared to unstimulated control neutrophils respectively 
(Figure 2.4, Table 2.2).  LPS treatment did not induce any apoptosis in neutrophils at 1 hr 
post infection while it caused significant apoptosis (around 6% higher as compared to 
time point unstimulated control neutrophils) at 6 hr post infection (p<0.05) (Figure 2.4, 
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Table 2.2). However, the staurosporine (STS) (positive control) induced around 13% and 
11% apoptosis in neutrophils at 1 hr and 6 hr post treatment, which were significantly 
higher as compared to the unstimulated control neutrophils (p<0.05)(Figure 2.4, Table 
2.2).   
Effect of BVDV on neutrophil surface marker expression  
 BVDV infection with either TGAC or TGAN had no effect on neutrophil CD14 
expression at 1 hr p.i. In contrast at 6 hr, CD14 expression increased approximately 12% 
and 27% following TGAC or TGAN infection as compared to their unstimulated time 
point control neutrophils (Table 2.3, Figure 2.5).  The positive control, LPS, a well-
known inducer of CD14, significantly enhanced neutrophil CD14 expression at 1 hr as 
well as 6 hr post treatment (p<0.05). This was approximately 200% and 300% higher at 1 
hr and 6 hr post treatment respectively as compared to its time point control (Table 2.3, 
Figure 2.5).  
Both TGAC and TGAN infection significantly reduced CD18 expression at 1 hr 
post infection, which was approximately 17% and 13% less than their unstimulated time 
point control neutrophils respectively (p<0.05) (Table 2.3, Figure 2.6). At 6 hr p.i. TGAN 
further reduced CD18 expression. The reduction in CD18 expression at 6 hr p.i. by 
TGAN was significant and was approximately 24% less as compared to unstimulated 
time point control neutrophils (p<0.05) (Table 2.3, Figure 2.6). However, homologous 
TGAC increased CD18 expression at 6 hr p.i. by approximately 8% as compared to 
unstimulated control neutrophils.  Neutrophils treated with LPS increased CD18 
expression by 2% and 15% higher at 1hr and 6 hr p.i. respectively as compared to 
unstimulated control neutrophils (Table 2.3, Figure 2.6). 
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LPS treatment also reduced the L-selectin expression by 4% and 29% at 1 and 6 
hr p.i. respectively, as compared to their time point control (Table 2.3, Figure 2.7). The 
reduction in L-selectin expression by LPS at 6 hr p.i. was significant as compared to their 
time point control (p<0.05)(Table 2.3, Figure 2.7). 
DISCUSSION 
The current study was conducted to standardize neutrophil isolation protocol with 
high yield, viability and purity. The effect of BVDV biotypes on neutrophil viability and 
phenotypic characteristics was measured. The optimized centrifugation, RBCs lysis and 
neutrophil restoration method in current study yielded 20.64±1.89 106 neutrophils from 
50 ml peripheral blood. Isolated neutrophils were 99.80±0.1% pure with 98.86±0.90 % 
viability. Freshly isolated neutrophils had high expression of CD18+ (99.77±0.13%), L-
selectin (97.05±2.41%), and low expression of CD14+ (11.34±3.89%) markers.  
Neither biotypes (eg. TGAC or TGAN) had any effect on neutrophil viability 
(p<0.05). A previous in vivo study showed that BVDV infection cause neutropenia in 
vivo (Roth et al., 1981) but they did not measure the effect BVDV on neutrophil viability. 
Such changes in neutrophil population could be due to reduced neutrophil production, 
margination or other hemodynamic mechanisms. However, the current study showed that 
BVDV infection significantly reduced CD18 and L-selectin expression on neutrophils. 
Both surface makers (e.g. CD14 or L-selectin) are needed for neutrophil margination and 
extravasation (Ley et al., 1995, Simon et al., 1995, Walzog et al., 1999, Kolaczkowska 
and Kubes, 2013).  Additionally, CD18 helped in inducing neutrophil maturation and 
release to the circulation from bone marrow (Gomez and Doerschuk, 2010). The 
crosslinking of L-selectin to its ligands upregulated CD18 expression (Green et al., 
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2003). Thus, reduced expression of L-selectin and CD18 may result in neutropenia due to 
reduced neutrophil production from the bone marrow.   
 In addition to surface marker expression, BVDV could affect neutrophil 
production through direct effect on hematopoietic cells. Studies with the highly virulent 
ncp BVDV2-890 and comparatively less virulent TGAN revealed that highly virulent ncp 
BVDV2-890 has higher association with lymphocytes and platelets as compared to the 
less virulent TGAN. The higher ability to infect and replicate in lymphocytes and in 
platelets by ncp BVDV2-890 may be a reason for lymphopenia, neutropenia and 
thrombocytopenia caused by ncp BVDV2-890 as compared to TGAN (Bolin and 
Ridpath, 1992).  
Similarly, an in vivo study with high virulent ncp BVDV2-HV24515 and low 
virulent ncp cp BVDV2-LV11Q revealed that both viruses cause neutropenia. However, 
the number of neutrophils rebounded earlier in low virulent ncp cp BVDV2-LV11Q 
infected animals as compared to high virulent ncp BVDV2-HV24515 infected animals. 
Rebound of neutrophil numbers was associated with bone marrow mononuclear cell 
(BMMCs) proliferation, which were isolated from each group. Results of that study 
suggested that BVDV induced neutropenia by affecting proliferative capacity of bone 
marrow progenitor cells (Keller et al., 2006). 
Another virus of the Flaviviridae family, dengue virus type 4, infected immature 
human bone marrow progenitor cells resulting in bone marrow failure and neutropenia 
(Nakao et al., 1989). Similarly, hepatitis C virus (HCV), another member of the 
Flaviviridae family, infected pluripotent hematopoietic CD34+ cells (Sansonno et al., 
1998), suggesting that HCV cause   neutropenia (Sheehan et al., 2014) this neutropenia 
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could be the results of affecting pluripotent hematopoietic CD34+ cell (Sansonno et al., 
1998) or through direct neutrophil apoptosis through caspases 3 and 10 (Aref et al., 
2011), or by both. 
In another in vivo study, neutrophils isolated from a BVDV persistently infected 
cattle had impaired neutrophil activity (Brown et al., 1991). However, this study in vivo 
which was a complete different environment then the current in vitro study. Additionally, 
that study did not measured the effect of BVDV on neutrophil surface marker expression, 
which helps determines the neutrophil functional ability.  
The current study measured the effect of two different BVDV biotypes, TGAC or 
TGAN, on neutrophil cell surface marker expressions. Both, TGAC or TGAN increased 
CD14 expression approximately 12% and 27% at 6 hr p.i. respectively, as compared to 
their unstimulated time point control neutrophils.  LPS that was used as positive control 
in assay significantly enhanced neutrophil CD14 expression at 1 hr as well as 6 hr post 
treatment (p<0.05). Upregulation of CD14 expression by LPS-positive control was 
approximately 200% and 300% higher at 1 hr and 6 hr post treatment respectively as 
compared to its time point control. (Jersmann et al., 1998; Landmann et al., 1996). 
The current study also revealed that TGAN infection significantly reduced CD18 
expression (p<0.05) while TGAC slightly enhanced the expression. Reduction in CD18 
expression by TGAN was about 24% while increment in CD18 expression by TGAC was 
about 8% at 6 hr p.i. as compared to their time point control neutrophil. However, both 
TGAC and TGAN significantly reduced L-selectin expression at 6 hr p.i. as compared to 
their time point control neutrophil (p<0.05). The reduction in L-selectin at 6 hr p.i. by 
both biotypes was approximately 11% as compared to their time point control 
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neutrophils. Downregulation of CD18 and L-selectin on neutrophils following BVDV 
infection indicated that BVDV infection could significantly affect neutrophil functional 
ability (Yoshitake et al., 2002). CD18 plays an important role in neutrophil maturation 
and its release into the circulation from bone marrow (Gomez and Doerschuk, 2010) as 
well as neutrophil extravasation from blood to tissues (Walzog et al., 1999).  
Similarly, L-selectin has adhesive properties to endothelium, which helped in 
extravasation of neutrophils from blood to tissues (Smolen et al., 2000). Additionally, 
crosslinking of L-selectin to its ligands was required for phosphorylation of mitogen-
activated protein kinases (MAPKs) leading activation of CD18 (Green et al., 2003). Thus, 
downregulation of L-selectin could further reduce the CD18 expression on neutrophils. 
Therefore, reduced L-selectin and CD18 could lead to reduced neutrophil production 
resulting neutropenia. This neutropenia and impaired neutrophil function was reported 
earlier in in vivo studies (Brown et al., 1991; Ganheim et al., 2005; Roth et al., 1981).  
In brief, the results of this study suggested that BVDV infection does not affect 
the viability of neutrophils. However, it reduced the L-selectin and CD18 expression 
leading to neutropenia and impaired neutrophil function.  Further studies need to be done 
with other BVDV strain inducing highly pathogenic and moderate pathogenic to evaluate 
the effect of BVDV pathogenicity of neutrophil surface marker expression.    
54 
 
 
REFERENCES 
Aref, S., Abdullah, D., Fouda, M., El Menshawy, N., Azmy, E., Bassam, A., Menessy, A., 
El Refaei, M. (2011). Neutrophil Apoptosis in Neutropenic Patients with 
Hepatitis C Infection: Role of Caspases 3, 10, and GM-CSF. Indian J Hematol 
Blood Transfus 27 (2): 81-87. 
 
Bai, F., Kong, K.F., Dai, J., Qian, F., Zhang, L., Brown, C.R., Fikrig, E., Montgomery, 
R.R. (2010). A paradoxical role for neutrophils in the pathogenesis of West Nile 
virus. J Infect Dis 202 (12): 1804-1812. 
 
Belmokhtar, C.A., Hillion, J., Segal-Bendirdjian, E. (2001). Staurosporine induces 
apoptosis through both caspase-dependent and caspase-independent mechanisms. 
Oncogene 20 (26):3354-3362. 
 
Bleyer, M., Curths, C., Dahlmann, F., Wichmann, J., Bauer, N., Moritz, A., Braun, A., 
Knauf, S., Kaup, F.J., Gruber-Dujardin, E.  (2016). Morphology and staining 
behavior of neutrophilic and eosinophilic granulocytes of the common marmoset 
(Callithrix jacchus). Exp Toxicol Pathol 68 (6): 335-343. 
 
Bolin, S. R., Ridpath, J.F. (1992). Differences in virulence between two noncytopathic 
bovine viral diarrhea viruses in calves. Am J Vet Res 53(11): 2157-2163. 
Brown, G.B., Bolin, S.R., Frank, D.E., Roth, J.A. (1991). Defective function of leukocytes 
from cattle persistently infected with bovine viral diarrhea virus, and the 
influence of recombinant cytokines. Am J Vet Res 52 (3): 381-387. 
 
Brownlie, J., Clarke, M.C., Howard, C.J. (1984). Experimental production of fatal 
mucosal disease in cattle. Vet Rec 114 (22): 535-536. 
 
55 
 
Buckwold, V.E., Beer, B.E., Donis, R.O. (2003). Bovine viral diarrhea virus as a surrogate 
model of hepatitis C virus for the evaluation of antiviral agents. Antiviral Res 60 
(1): 1-15. 
 
Chase, C.C., Elmowalid, G., Yousif, A.A. (2004). The immune response to bovine viral 
diarrhea virus: a constantly changing picture. Vet Clin North Am Food Anim 
Pract 20 (1): 95-114. 
 
Chazotte, B. (2011). Labeling nuclear DNA using DAPI. Cold Spring Harb Protoc 2011 
(1): pdb prot5556. 
 
Chung, F.M., Tsai, J.C., Chang, D.M., Shin, S.J., Lee, Y.J. (2005). Peripheral total and 
differential leukocyte count in diabetic nephropathy: the relationship of plasma 
leptin to leukocytosis. Diabetes Care 28 (7): 1710-1717. 
 
Ganheim, C., Johannisson, A., Ohagen, P., Persson Waller, K. (2005). Changes in 
peripheral blood leucocyte counts and subpopulations after experimental 
infection with BVDV and/or Mannheimia haemolytica. J Vet Med B Infect Dis 
Vet Public Health 52(9): 380-385. 
 
Gao, J.X., Issekutz, A.C. (1996). Mac-1 (CD11b/CD18) is the predominant beta 2 (CD18) 
integrin mediating human neutrophil migration through synovial and dermal 
fibroblast barriers. Immunology 88(3): 463-470. 
 
Glew, E.J., Carr, B.V., Brackenbury, L.S., Hope, J.C., Charleston, B., Howard, C.J. 
(2003). Differential effects of bovine viral diarrhoea virus on monocytes and 
dendritic cells. J Gen Virol 84 (7): 1771-1780. 
 
Gomez, J.C., Doerschuk, C.M. (2010). The role of CD18 in the production and release of 
neutrophils from the bone marrow. Lab Invest 90(4): 599-610. 
 
56 
 
Green, C.E., Pearson, D.N., Christensen, N.B., Simon, S.I. (2003). Topographic 
requirements and dynamics of signaling via L-selectin on neutrophils. Am J 
Physiol Cell Physiol 284 (3): C705-717. 
 
Guo, R.F., Riedemann, N.C., Bernacki, K.D., Sarma, V.J., Laudes, I.J., Reuben, J.S., 
Younkin, E.M., Neff, T.A., Paulauskis, J.D., Zetoune, F.S., Ward, P.A. (2003). 
Neutrophil C5a receptor and the outcome in a rat model of sepsis. FASEB J 17 
(13): 1889-1891. 
 
Hay, K.E., Ambrose, R.C., Morton, J.M., Horwood, P.F., Gravel, J.L., Waldron, S., 
Commins, M.A., Fowler, E.V., Clements, A.C., Barnes, T.S., Mahony, T.J. 
(2016). Effects of exposure to Bovine viral diarrhoea virus 1 on risk of bovine 
respiratory disease in Australian feedlot cattle. Prev Vet Med 126: 159-169. 
 
Jaillon, S., Galdiero, M.R., Del Prete, D., Cassatella, M.A., Garlanda, C., Mantovani, A. 
(2013). Neutrophils in innate and adaptive immunity. Semin Immunopathol 
35(4): 377-394. 
 
Jersmann, H.P., Rathjen, D.A., Ferrante, A. (1998). Enhancement of lipopolysaccharide-
induced neutrophil oxygen radical production by tumor necrosis factor alpha. 
Infect Immun 66 (4): 1744-1747. 
 
Keller, S. L., Jefferson, B.J., Jacobs, R.M., Wood, R.D. (2006). Effects of noncytopathic type 2 
bovine viral diarrhea virus on the proliferation of bone marrow progenitor cells. Can J 
Vet Res 70(1): 20-27. 
Kobayashi, S.D., DeLeo, F.R. (2009). Role of neutrophils in innate immunity: a systems 
biology-level approach. Wiley Interdiscip Rev Syst Biol Med 1(3): 309-333. 
 
Kolaczkowska, E., Kubes, P. (2013). Neutrophil recruitment and function in health and 
inflammation. Nat Rev Immunol 13(3): 159-175. 
57 
 
Landmann, R., Knopf, H.P., Link, S., Sansano, S., Schumann, R., Zimmerli, W. (1996). 
Human monocyte CD14 is upregulated by lipopolysaccharide. Infect Immun 
64(5): 1762-1769. 
 
Ley, K., Bullard, D.C, Arbones, M.L., Bosse, R., Vestweber, D., Tedder, T.F., Beaudet, 
A.L. (1995). Sequential contribution of L- and P-selectin to leukocyte rolling in 
vivo. J Exp Med 181(2): 669-675. 
Lustig, Y., Lanciotti, R.S., Hindiyeh, M., Keller, N., Milo, R., Mayan, S., Mendelson, E. 
(2016). Mutation in West Nile Virus Structural Protein prM during Human 
Infection. Emerg Infect Dis 22 (9). 
 
Mantovani, A., Cassatella, M.A., Costantini, C., Jaillon, S. (2011). Neutrophils in the 
activation and regulation of innate and adaptive immunity. Nat Rev Immunol 11 
(8) 519-531. 
 
Marino, G., Kroemer, G. (2013). Mechanisms of apoptotic phosphatidylserine exposure. 
Cell Res 23(13): 1247-1248. 
 
McAvoy, E.F., McDonald, B., Parsons, S.A., Wong, C.H., Landmann, R., Kubes, P. 
(2011). The role of CD14 in neutrophil recruitment within the liver 
microcirculation during endotoxemia. J Immunol 186 (4): 2592-2601. 
 
Mitchell, G.B., Albright, B.N., Caswell, J.L. (2003). Effect of interleukin-8 and 
granulocyte colony-stimulating factor on priming and activation of bovine 
neutrophils. Infect Immun 71 (4): 1643-1649. 
 
Mitchell, M.J., Lin, K.S., King, M.R. (2014). Fluid shear stress increases neutrophil 
activation via platelet-activating factor. Biophys J 106 (10): 2243-2253. 
 
58 
 
Nakao, S., C. J. Lai and N. S. Young (1989). Dengue virus, a flavivirus, propagates in 
human bone marrow progenitors and hematopoietic cell lines. Blood 74(4): 
1235-1240. 
 
Rajput, M.K., Darweesh, M.F., Park, K., Braun, L.J., Mwangi, W., Young, A.J., Chase, 
C.C.L. (2014). The effect of bovine viral diarrhea virus (BVDV) strains on 
bovine monocyte-derived dendritic cells (Mo-DC) phenotype and capacity to 
produce BVDV. Virol J 11: 44. 
 
Richer, L., Marois, P., Lamontagne, L. (1988). Association of bovine viral diarrhea virus 
with multiple viral infections in bovine respiratory disease outbreaks. Can Vet J 
29(9): 713-717. 
 
Ridpath, J. F. (2012). Preventive strategy for BVDV infection in North America. Jpn J Vet 
Res 60 Suppl, 41-49. 
 
Ridpath, J.F., Lewis, T.L., Bolin, S.R., Berry, E.S. (1991). Antigenic and genomic 
comparison between non-cytopathic and cytopathic bovine viral diarrhoea 
viruses isolated from cattle that had spontaneous mucosal disease. J Gen Virol 72 
(3): 725-729. 
 
Risalde, M.A., Molina, V., Sanchez-Cordon, P.J., Pedrera, M., Panadero, R., Romero-
Palomo, F., Gomez-Villamandos, J.C. (2011). Response of proinflammatory and 
anti-inflammatory cytokines in calves with subclinical bovine viral diarrhea 
challenged with bovine herpesvirus-1. Vet Immunol Immunopathol 144(1-2): 
135-143. 
 
Roth, J.A., Kaeberle, M.L., Griffith, R.W. (1981). Effects of bovine viral diarrhea virus 
infection on bovine polymorphonuclear leukocyte function. Am J Vet Res 42 (2): 
244-250. 
59 
 
 
Rypula, K. (2003) The effects of experimental infection with bovine diarrhoea virus 
(BVDV) on lymphocyte subpopulations in the peripheral blood of pigs. Pol J Vet 
Sci 6 (3): 189-193 
. 
Sansonno, D., Lotesoriere, C., Cornacchiulo, V., Fanelli, M., Gatti, P., Iodice, G., 
Racanelli, V., Dammacco, F. (1998). Hepatitis C virus infection involves 
CD34(+) hematopoietic progenitor cells in hepatitis C virus chronic carriers. 
Blood 92(9): 3328-3337. 
 
Segawa, K., Nagata, S. (2015). An Apoptotic 'Eat Me' Signal: Phosphatidylserine 
Exposure. Trends Cell Biol 25 (11): 639-650. 
 
Sheehan, V. A., Weir, A., Waters, B. (2014). "Hepatitis C and neutropenia." Curr Opin 
Hematol 21(1): 58-63. 
Simon, S. I., Burns, A.R., Taylor, A.D., Gopalan, P.K., Lynam, E.B., Sklar, A.L., Smith, 
W.C. (1995). "L-selectin (CD62L) cross-linking signals neutrophil adhesive 
functions via the Mac-1 (CD11b/CD18) beta 2-integrin." J Immunol 155(3): 
1502-1514. 
Smolen, J.E., Petersen, T.K., Koch, C., O'Keefe, S.J., Hanlon, W.A., Seo, S., Pearson, D., 
Fossett, M.C., Simon, S.I. (2000). L-selectin signaling of neutrophil adhesion and 
degranulation involves p38 mitogen-activated protein kinase. J Biol Chem 275 
(21): 15876-15884. 
 
Strober, W. (2001). Trypan blue exclusion test of cell viability. Curr Protoc Immunol 
Appendix 3, Appendix 3B. 
 
Van Campen, H. (2010). Epidemiology and control of BVD in the U.S. Vet Microbiol 142 
(1-2): 94-98. 
60 
 
 
von Andrian, U.H., Chambers, J.D., Berg, E.L., Michie, S.A., Brown, D.A., Karolak, D., 
Ramezani, L., Berger, E.M., Arfors, K.E., Butcher, E.C. (1993). L-selectin 
mediates neutrophil rolling in inflamed venules through sialyl LewisX-dependent 
and -independent recognition pathways. Blood 82 (1): 182-191. 
 
Walzog, B., Scharffetter-Kochanek, K., Gaehtgens, P. (1999). Impairment of neutrophil 
emigration in CD18-null mice. Am J Physiol 276 (5-1): G1125-1130. 
 
Wang, P., Bai, F., Zenewicz, L.A., Dai, J., Gate, D., Cheng, G., Yang, L., Qian, F., Yuan, 
X., Montgomery, R.R., Flavell, R.A., Town, T., Fikrig, E. (2012). IL-22 
signaling contributes to West Nile encephalitis pathogenesis. PLoS One 7 (8) 
:e44153. 
 
Yoshitake, H., Takeda, Y., Nitto, T., Sendo, F. (2002). Cross-linking of GPI-80, a possible 
regulatory molecule of cell adhesion, induces up-regulation of CD11b/CD18 
expression on neutrophil surfaces and shedding of L-selectin. J Leukoc Biol 71 
(2): 205-211. 
61 
 
 
 
Figure 2.1. Morphologic characterization of isolated bovine neutrophils. 
Freshly isolated bovine neutrophils were cytospun and fixed with methanol 
followed by H and E staining or stained with DAPI. H and E staining of 
neutrophils showed purple colored multiple lobes in nucleus (polymorphic 
nucleus-red arrow) (A). Similar multiple lobes in nucleus (polymorphic nucleus) 
with blue color (shown with red arrow) were observed following DAPI staining 
Cells were examined at 20X using compound microscope (Olympus, PA, USA) 
(A) or fluorescent microscope (Olympus, PA, USA) (B) 
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Figure 2.2. Phenotype of bovine neutrophils. Bovine neutrophils were stained 
with anti-CD18, anti-L-selectin and anti-CD14 antibodies followed by FITC-
labeled secondary antibody. The percentage of cells expressing CD18 
(99.77±0.13) (A), L-selectin (97.05±2.41) (B) and CD14 (11.34±3.89) (C) in M1 
gating, shown by red arrow were measured using FACScan flow cytometer 
(Becton-Dickson, Mountain View, CA).  
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Figure 2.3. Neutrophils viability following BVDV infection. Neutrophils were infected 
with TGAC or TGAN at a MOI 6 for 0 hr, 1 hr and 6 hr. Mock-infected or LPS 
(10ng/ml) treated neutrophils were used as negative or positive controls respectively. 
Neutrophil viability was examined for through trypan blue exclusion assay and examined 
for significant differences using paired T test (p<0.05). 
 
 
64 
 
 
Figure 2.4. Effect of BVDV in inducing apoptosis in neutrophils. Neutrophils 
were infected with TGAC or TGAN at a MOI 6 for 0 hr, 1 hr and 6 hr. Mock-
infected, or staurosporine (STS) 10nM treated neutrophil were used as negative or 
positive controls respectively. LPS (10ng/ml) also used for neutrophil stimulation. 
Neutrophil apoptosis was measured through Annexin V Apoptosis Detection Kit 
(eBiosciences, San Diego, CA). Significant differences from unstimulated control 
cells was calculated using paired T-test (p<0.05). Significant differences in 
treatment are shown with asterisk (*)  
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Figure 2.5. Effect of BVDV infection of CD14 expression on neutrophils. 
Freshly isolated neutrophils were infected with TGAC or TGAN at a MOI of 6 
or treated with LPS (10ng/ml). Neutrophils were collected at 0 hr, 1 hr or 6 hr 
post infection/treatment. Neutrophils were then stained with anti-CD14 
antibodies. Followed by FITC-labeled secondary antibody.  After secondary 
antibody staining, cells were analyzed through FACScan (Becton-Dickson, 
Mountain View, CA). Significant difference in surface marker expression 
following BVDV infection or LPS-treatment then its time point control was 
calculated through paired T-test (p<0.05) and indicated with an asterisk (*).  
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Figure 2.6. Effect of BVDV infection of CD18 expression on neutrophils. 
Freshly isolated neutrophils were infected with TGAC or TGAN at a MOI of 6 or 
treated with LPS (10ng/ml). Neutrophils were collected at 0 hr, 1 hr or 6 hr post 
infection/treatment. Neutrophils were then stained with anti-CD18 antibodies. 
Cells were analyzed using a FACScan flow cytometer (Becton-Dickson, 
Mountain View, CA). Significant difference in surface marker expression 
following BVDV infection or LPS-treatment at each time point were calculated 
using a paired T-test (p<0.05) and are shown with an (*).  
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Figure 2.7. Effect of BVDV infection of L-selectin expression on neutrophil. 
Freshly isolated neutrophils were infected with TGAC or TGAN at a MOI of 6 or 
treated with LPS (10ng/ml). Neutrophils were collected at 0 hr, 1 hr or 6 hr post 
infection/treatment. Neutrophils were then stained with anti-L-selectin antibodies 
and using flow cytometry. Significant differences in surface marker expression 
following BVDV infection vs. LPS-treatment at each time point were determined 
using a paired T-test (p<0.05) and statistical differences were indicated with an 
asterisk sign (*).  
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TABLES 
 
Treatment  0 hr 1 hr 6 hr 
Control (Unstimulated neutrophils) 99.39±0.93% 99.17± 1.41% 98.13± 2.65% 
Neutrophils treated with LPS 
(10ng/ml) 
99.39±0.93% 98.25± 1.82 93.43± 3.08 
Neutrophils infected with TGAC (6 
MOI) 
99.39±0.93% 98.08± 1.26 97.33± 2.08 
Neutrophils infected with TGAN (6 
MOI) 
99.39±0.93% 99.25± 1.27 97.10± 1.09 
 
Table 2.1. Neutrophils viability following BVDV infection. Neutrophils were infected 
with TGAC or TGAN at a MOI 6 for 0 hr, 1 hr and 6 hr. Mock-infected or LPS-treated 
neutrophils were used as negative or positive controls respectively. Neutrophil viability 
was examined for through trypan blue exclusion assay and examined for significant 
differences using a paired T test (p<0.05). 
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Treatment 0 hr 1 hr 6 hr 
Control (Unstimulated neutrophils) 5.39±0.48% 20.17± 5.58% 37.11± 2.41% 
Neutrophils treated with LPS 
(10ng/ml) 
5.39±0.48% 18.55± 3.43 43.49±2.53* 
Neutrophils treated with 
staurosporine (STS) 10nM (positive 
control) 
5.39±0.48% 33.82±0.00* 48.62±2.82* 
Neutrophils infected with TGAC (6 
MOI) 
5.39±0.48% 23.23±6.94 41.20± 1.58 
Neutrophils infected with TGAN (6 
MOI) 
5.39±0.48% 27.49± 1.97* 38.72± 1.18 
 
Table 2.2. Effect of BVDV in inducing apoptosis in neutrophils. Neutrophils were 
infected with TGAC or TGAN at a MOI 6 for 0 hr, 1 hr and 6 hr. Mock-infected, or 
staurosporine (STS) 10nM treated neutrophil were used as negative or positive controls 
respectively. LPS (10ng/ml) also was used for neutrophil stimulation. Apoptosis in 
neutrophil was measured with Annexin V Apoptosis Detection Kit (eBiosciences, San 
Diego, CA). Significant differences from unstimulated control cells was calculated using 
a paired T-test (p<0.05). Significant differences in treatment are indicated with an 
asterisk sign (*). 
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 CD14 CD18 L-selectin  
 0 hr 1hr 6 hr 0 hr 1hr 6 hr 0 hr 1hr 6 hr 
Control 
(Unstimulated 
Neutrophils)  
100 
±0.00 
103.91 
±27.83 
118.93 
±34.20 
100 
±0.00 
123.21 
±19.28 
78.13 
±14.65 
100 
±0.00 
75.47 
±18.96 
56.82 
±5.69 
Neutrophils 
treated with 
LPS 
(10ng/ml) 
100 
±0.00 
204.41 
±6.25* 
360.52 
±26.30* 
100 
±0.00 
126.33 
±2.31 
90.24 
±2.14 
100 
±0.00 
72.72 
±6.20 
40.33 
±5.69* 
Neutrophils 
infected with 
TGAC (6 
MOI) 
100 
±0.00 
104.54 
±35.02 
133.97 
±43.17 
100 
±0.00 
103.08 
±11.85* 
84.46 
±20.83 
100 
±0.00 
82.73 
±11.86 
50.34 
±7.35* 
Neutrophils 
infected with 
TGAN (6 
MOI) 
100 
±0.00 
100.81 
±27.99 
151.19 
±43.23 
100 
±0.00 
108.50 
±26.11* 
59.79 
±3.56* 
100 
±0.00 
80.87 
±18.03 
50.56 
±4.48* 
 
Table 2.3. Effect of BVDV infection of cell surface marker expression CD14, CD18 
and L-selectin on neutrophils. Freshly isolated neutrophils were infected with TGAC or 
TGAN at a MOI of 6 or treated with LPS (10ng/ml). Neutrophils were collected at 0 hr, 1 
hr or 6 hr post infection/treatment. Neutrophils were then stained with anti-CD14, anti-
CD18 and anti-L-selectin antibodies, followed by FITC-labeled secondary antibody.  
After secondary antibody staining, cells were analyzed using flow cytometer. Significant 
differences in surface marker expression following BVDV infection or LPS-treatment 
then its time point control was calculated with a paired T-test (p<0.05) and are shown 
with an asterisk (*).  
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CHAPTER 3. 
EFFECT OF BVDV ON FUNCTIONAL ABILITY OF BOVINE NEUTROPHILS  
ABSTRACT 
Bovine viral diarrhea virus (BVDV) is one of the highly prevalent and 
economically devastating diseases of the cattle industry worldwide. The two major 
consequences of BVDV infection are persistent infection and immunosuppression. 
Several studies have been done to determine the underline mechanisms for BVDV-
induced immunosuppression, targeting antigen presenting cells, cells of adaptive immune 
system and cytokine gene expression. However, very little research has focused on the 
effect of BVDV on neutrophils.  
Neutrophils are one of the most abundant white blood cell (WBC) in the 
peripheral blood and play a critical role in innate as well as adaptive immune response. 
During injury or pathogen invasion, neutrophils become activated and migrate to the site 
of infection. At the site of infection, neutrophils phagocytize and destroy the invading 
pathogen through intracellular phagosomes and/or reactive oxygen species.  In some 
cases, neutrophils also use extracellular traps to eliminate the invading pathogen.  
The effect of BVDV infection on neutrophil functions, migration/chemoattraction, 
phagocytosis, oxidative burst and NET formation, were measured. The three ncp strains 
enhanced migration while the cp strain reduced neutrophil migration as compared to the 
mock-infected control treatment.  The number of neutrophil that reached the lower 
chamber were 139%, 350% or 44% higher in TGAN, 1373 or 28508-infected 
macrophages as compared to mock-infected macrophage control, respectively. The 
number of neutrophils that migrated to TGAC-infected macrophages was 10% less as 
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compared to mock-infected control neutrophils. Compared with LPS-treated positive 
macrophage, all strains infection except the highly virulent 1373, reduced neutrophil 
migration. The enhancement in neutrophil migration by 1373 was approximately 55% 
higher as compared to LPS-treated positive control macrophages.  
BVDV infection by any of the four strains significantly enhanced neutrophil 
phagocytosis activity of 0.2 µm microsphere beads as compared to mock infection 
(p<0.05). Phagocytosis activity following TGAC, TGAN, 28508 or 1373 infection was 
approximately 159%, 816%, 384% and 741% higher as compared to mock-infected 
control neutrophils respectively. Compared with LPS-treated positive control neutrophils, 
the 4 BVDV strains significantly reduced the phagocytosis of microsphere beads 
(p<0.05). Neutrophils infected with TGAC, TGAN, 1373 or 28508 reduced phagocytosis 
activity as 78.9%, 25.7%, 60% or 31.8% respectively, as compared to LPS-treated 
neutrophils.   
Neutrophil phagocytic activity of rhodamine-labeled-E. coli was significantly 
reduced by BVDV infection. TGAC, TGAN, 1373 or 28508 had 23%, 6%, 19% or 12% 
less phagocytic activity as compared to mock-infected rhodamine-labeled-E. coli-treated 
neutrophils (p<0.05).  
BVDV significantly enhanced the NET formation as compare to mock-infected 
negative control neutrophils (p<0.05).  NET formation following TGAC, TGAN, 1373 or 
28508 infection was observed at 102.82±4.83%, 106.91±7.58%, 107.04±6.72 % and 
111.01±10.86% respectively as compared to the LPS positive control.  NET formation 
was dramatic higher 179%, 190%, 190% and 201% higher as compared to mock-infected 
negative control neutrophils (37%)   
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These results indicated that BVDV infection modulates neutrophil activity of 
migration, phagocytosis and oxidative burst in a strain-dependent manner. All strains 
reduced neutrophil phagocytosis and oxidative burst activity, indicating that BVDV 
infection likely enhanced the susceptibility of secondary bacterial infection.  
   
INTRODUCTION 
  Bovine viral diarrhea virus (BVDV) is one of the most widespread viruses in the 
cattle industry.  It is a single-stranded, positive-sense RNA virus with a genome of 
approximately 12.5 kb (Renard et al., 1985).  The BVDV genome encodes a single open 
reading frame flanking with a 5′-nontranslated region (5′-NTR) and a 3′-untranslated 
region (3′-NTR) (Fan and Bird, 2012; Wiskerchen et al., 1991).  The polyprotein is 
cleaved into 11-12 structural or non-structural viral proteins either by host or viral 
proteases (Kummerer et al., 1998; Wiskerchen et al., 1991). The genetic diversity 
between different strains of BVDV has resulted in the classification of BVDV into two 
genotypes based on highly conserved 5’UTR region: BVDV Type I and BVDV Type II 
(Ridpath, 2003). BVDV can also be divided into two biotypes: cytopathic (cp) BVDV 
and noncytopathic (ncp) BVDV based on their effect in cell culture (Baker, 1987).  
BVDV produces a wide range of clinical symptoms. The severity of the disease 
can range from mild acute infection to severe infection depending on the virulence of 
strain and health of infected host (Chase et al., 2015). A common feature of all BVDV 
infections are immunosuppression. Several studies determined the effect of BVDV on the 
adaptive response from antigen presenting to T cell activation and B cell responses 
(Chase, 2013; Chase et al., 2015). However, few studies have determined the effect of 
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BVDV on neutrophils, specifically the comparative effect of BVDV biotypes and strains 
with different virulence.  Neutrophils are the major white blood cell in circulation, which 
play an important role innate immune response as well as activating and shaping the 
adaptive immune response (Jaillon et al., 2013).  This study was designed to measure the 
effect of BVDV on neutrophil functional activity using a variety of BVDV strains: 
homologous pair of ncp and cp viruses (e.g. ncp BVDV1b TGAN and cp BVDV1b 
TGAC) recovered from an animal that died of mucosal disease as well as highly virulent, 
ncp BVDV2a 1373 and moderate virulent ncp BVDV2a 28508-5 strains.    
MATERIALS AND METHODS 
Virus Strains and Preparation 
A homologous pair of ncp and cp type 1b viruses, ncp BVDV1b TGAN and cp 
BVDV1b TGAC (Brownlie et al., 1984), highly virulent ncp BVDV2a 1373 and 
moderate virulent ncp BVDV2a 28508-5 strains were used.  Virus stocks of each strain 
was prepared in BVDV-free Madin Darby bovine kidney (MDBK) cells as described in 
chapter two. Briefly, BVDV-free MDBK cells (passage 98-112) were grown in minimal 
essential medium (MEM, Gibco BRL, Grand Island, NY) (pH 7-7.4) supplemented with 
10% BVDV-free fetal calf serum (FCS) (PPA, Pasching, Austria), penicillin (100 U /ml) 
and streptomycin (100 μg /ml).  Five (5) ml of 5x105 MDBK cells/ml were seeded in T25 
flasks using minimal essential medium (MEM, Gibco BRL, Grand Island, NY) 
supplemented with 10% FBS, penicillin (100 U/ml) and streptomycin (100μg/ml) 
(Sigma-Aldrich, St. Louis, MO, USA). MDBK cells with 60-70% confluency were 
infected with either viral strain.  During viral infection, the media from each flask was 
replaced with and 0.75 ml of virus inoculum with a multiplicity of infection [MOI] of 
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one. Virus was adsorbed for 1 hr at 37°C in a humidified CO2 incubator with gentle 
rotation at every 15 minutes. After one hr incubation, unabsorbed virus was removed and 
the cells were washed with sterile PBS. After washing, 5 ml MEM medium supplemented 
with 10% FBS, penicillin (100 U/ml) and streptomycin (100μg/ml) was added to each 
flask.  The cells were incubated at 37°C in a humidified CO2 incubator for 4-5 days or up 
to 70-80% cytopathic effect for TGAC.  After 4-5 days of incubation, cells were frozen at 
(-80˚C for 15 minutes) and thawed on ice for two cycles.  The cell debris were pelleted 
by centrifugation at 3000 rpm for 10 min at 4°C in 15 ml conical tubes.  The 
supernatants, containing virus, were carefully collected. Supernatants were titrated for 
virus concentration and then aliquoted and stored at -80°C for further use.  
The viral titer was determined by serially inoculating 1:10 dilutions in MEM 
containing MDBK cells as per the method described earlier (Reed and Muench, 1938).  
Briefly MDBK cells were detached from tissue culture flask using 0.25% trypsin-EDTA 
(Sigma-Aldrich, St. Louis, MO, USA). The number of cells was adjusted to 5x105 cells/ 
ml.  One hundred eighty (180) µl cell suspension was added to each well of 96-well plate. 
Twenty (20) µl of virus was added to the first row of the plate. The virus was then mixed 
with MDBK cells and 20 µl of this dilution was added to next row to achieve 10-fold 
dilutions.  The last two rows were treated as negative controls with no virus. The plates 
were incubated at 37°C in humidified incubator for next 4 days. The plate was examined 
every day for cytopathic effect (CPE). The highest dilution showing CPE was used as 
endpoint to calculate the proportionate distance (PD). The PD was then used to determine 
the viral concentration (TCID50) as per formula as described earlier (Reed and Muench, 
1938). 
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5. Proportionate distance (PD) = (% CPE at dilution above 50%) – (50%)/ (% CPE 
at dilution above 50%)- (% CPE at dilution below 50%) (e.g.  60-50/60-0= 0.166) 
6. Calculation of endpoint just next to 50% CPE and conversion into – Log (e.g.10-6 
dilution would be -6) 
7. Calculation of TCID50.  
8.  TCID50 for 20 µl= (PD+ - Log dilution above 50%)  (e.g. 1x106.166) 
For ncp BVDV, the same procedures were done except the endpoint for ncp 
BVDV was determined by staining the MDBK cells with anti-BVDV antibody (mAb 
16C6: IDEXX Laboratories, Westbrook, ME, USA) followed by biotinylated rabbit anti-
mouse IgG (Zymed, Invitrogen Corporation, Frederick, MD, USA), streptavidin-HRP 
(Invitrogen Corporation, Camarillo, CA, USA) and AEC reagent (3 amino-9 ethyl-
carbazole) (Sigma-Aldrich, St. Louis, MO, USA). The endpoint for ncp BVDV was 
determined by the presence of BVDV positive red stained cells.  
Animals  
Sixteen (14) healthy cattle (Holstein Friesian (n=9) and Brown Swiss calves (n=5) 
(8-12 months of age) housed at Department of Dairy Science’s Dairy Farm, South Dakota 
State University (SDSU), Brookings, SD, USA were used in this study. The SDSU 
Institutional Animal Care and Use Committee approved animal handling and blood 
collection. 
Neutrophil Isolation and Viability 
To isolate neutrophils, fifty (50) ml of peripheral blood was collected in 10 ml 
heparinized vacutainer tubes (BD, Franklin Lakes, New Jersey, USA) as described in 
chapter two.  Briefly, neutrophils along with red blood cells (RBCs) were separated by 
centrifuging the blood at 1,000 X g for 30 minutes at 25°C. The plasma and buffy coat 
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were removed and discarded.  The 3-ml cell pellet (neutrophils+ RBCs) was placed into 
eight (8)-15 ml conical tubes.  To each 15-ml conical tube, 10 ml of RBC lysing solution 
was added.  Each tube was gently inverted several times for 10 minutes to lyse the RBCs. 
After gentle inverting, tubes were centrifuged at 1,000 X g for 5 minutes at 25°C.  
Supernatants were discarded and cells pellets were washed 3 times using 10 ml of HBSS 
(for each tube, then were centrifuged at 1,000 X g for 5 minutes at 25°C).  After each 
wash, cell pellets from two tubes were combined to one, leaving 4 tubes, 2 tubes and 1 
tube at the end of each wash (after three wash, cells from eight tubes were combined to 
one tube).  The final cell pellet was suspended in 10 ml RPMI 1640 medium (MEM, 
Gibco BRL, Grand Island, NY) supplemented with 10% BVDV free fetal calf serum 
(FCS) (PPA, Pasching, Austria), sodium pyruvate, penicillin (100 U/ml) and 
streptomycin (100μg/ml) (Sigma-Aldrich, St. Louis, MO, USA). A 2.06±1.89 106/ml (in 
a final volume of 10 ml) neutrophils with 98.86±0.90% viability. 
Effect of BVDV on neutrophil migration ability 
The effect of BVDV on the neutrophil migration was measured using collagen-
coated 6.5 mm transwell plates (Corning life Sciences, Corning, NY).  Briefly, monocyte 
derived macrophages (MDM) were seeded and infected with BVDV in a 24-well plate 
(lower part of the transwell plate) while freshly collected neutrophils were added to upper 
chamber of the transwell. The number of neutrophils migrating to the lower well after 
one hour was used to estimate neutrophil migration ability.  
The neutrophil migration assay was conducted as follows: 
A. Generation of monocyte derived macrophage (MDM): 
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  Sixty (60) ml heparinized venous blood was collected using 6-10 ml heparinized 
vacutainers tubes through adopter needles from healthy calves.  Freshly collected 
heparinized blood was centrifuged at 2000 rpm for 30 minutes at 4°C to collected buffy 
layers.  Cells from buffy layer were suspended into heparinized (10 U/ml) PBS in 1:3 
ratio. The 10 ml of diluted cells were overlaid on a 3 ml, 65% Percoll (GE Healthcare 
Biosciences, Pittsburgh, PA, USA) in 15 ml conical tubes (Falcon, Oxnard, CA, USA). 
After the cells were overlaid, the cells were centrifuged for at 2000 rpm, 4°C for 30 
minutes. The white cell layer containing PBMC were aspirated by pipette from the 
interphase. The collected PBMC were washed two times using heparinized PBS (10 
U/mL) by centrifugation at 1700 rpm for 15 min at 4°C. Finally, PBMC were 
resuspended in complete RPMI medium [RPMI 1640 medium supplemented with 10% 
FBS, penicillin (100 U/ml) and streptomycin (100μg/ml)] to achieve a final concentration 
of 1X 106 cells/ ml. Three (3) ml of the cell suspension was added to each well of a 6-
well plate (Falcon, Oxnard, CA, USA) and incubated at 37°C in a humidified CO2 
incubator for 3 hour. After 3-hour attachment, non-adherent cells were washed away 
using pre-warmed PBS.  Adherent monocytes were cultured for 5 days by changing one-
half of the media every other day.  
B. BVDV infection to monocyte derived macrophages (MDM):  
On the 5th day of culture, MDM were detached with 0.5 ml/well Accutase 
(eBioscience, San Diego, CA, USA) and dissolved in complete RPMI medium to achieve 
a final concentration of 5x105 cell/ml.  One (1) ml of MDM cells was seeded to each well 
of 24 well plates and allowed to attach overnight at 37 °C. The following day, MDM 
were infected with either TGAC, TGAN, 1373 or 28508 at a MOI of 6. Mock-infected or 
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LPS–treated (10ng/ml) MDM were used as negative and positive controls respectively. 
After one-hour adsorption/treatment, MDM were washed with PBS and each well was 
supplemented with fresh 0.6 ml complete RPMI medium (Figure 3.1). 
C. Neutrophil transwell migration assay 
Freshly collected neutrophils were resuspended in complete RPMI medium to a 
final concentration of 1x106 cell/ml.  One hundred (100) µl of the cell suspension was 
placed in the upper chamber of the transwell and the plate was incubated at 37°C for one 
hour (Figure 3.1). After one-hour incubation, a digital image of neutrophils migrated to 
lower chamber were taken.  After migration, activated neutrophils were tightly attached to 
the lower chamber of transwell and Accutase/trypsin was unable to detach all cells. For 
better accuracy, cells were counted using ImageJ software.  At least six images from 
different fields at 20X magnification were taken through a microscope (Olympus, Center 
Valley, PA) and number of cells in each field was counted using ImageJ software 
(Schneider et al., 2012). 
Effect of BVDV on phagocytic activity on neutrophils  
A. Effect of BVDV on phagocytic activity on neutrophils using fluorescent beads as target 
The effect of BVDV on neutrophil phagocytic activity was measured using a 
homologous pair, TGAC and TGAN, highly virulent BVDV2a 1373 or moderate virulent 
BVDV2a 28508. Briefly, freshly collected bovine neutrophils were infected with either 
strain at a MOI of 6 for 1 hour. Mock-infected or LPS-treated (10ng/ml) neutrophils were 
used as negative and positive controls respectively. After one-hour infection/treatment, 
neutrophils were washed with PBS once. During washing, neutrophils from respective 
well of 6-well plates were transferred to 15 ml conical tubes. Tubes were centrifuged at 
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500xg for 10 minutes at 25°C. After centrifugation, supernatant was discarded and the 
pellet was resuspended in 5 ml PBS by gentle pipetting. Neutrophils were centrifuged at 
500xg for 10 minutes at 25°C and resuspended in RPMI media supplemented with 10% 
FBS and antibiotics to achieve final concentration 5x105/ml.  One (1) ml neutrophils from 
each treatment was transferred to 24-well plates.  To these plates, 0.2 µm red (580/605) 
carboxylated-modified microsphere beads (Thermo Fisher, Waltham, MA) were added at 
1:10 target effector ratio. The neutrophil-bead mixture was incubated at 37 °C for one 
hour and then washed with PBS by centrifugation at 1000xg for 10 minutes at 4°C.  The 
neutrophil-bead pellet was resuspended and fixed with 200µl 1% paraformaldehyde in 
PBS.  Fixed cells were transferred to individual well of 24-well plates and examined 
under fluorescent microscope (Olympus, Center Valley, PA).  The percent phagocytosis 
was calculated with following formula  
 
Percent phagocytosis= Number of neutrophils with phagocytized beads X 
100/Total number of neutrophils  
 
B. Effect of BVDV on phagocytic activity on neutrophils using rhodamine-labeled E. coli 
as target  
The effect of BVDV infection on phagocytic activity of neutrophils was further 
examined through rhodamine-labeled-E. coli.  Briefly, E. coli (DH5-Alpha), was streaked 
on nutrient agar plate and incubated overnight at 37°C in humidified incubator. After 
overnight incubation, a single colony of E. coli was collected and propagated in Luria-
Bertani (LB) broth for 8 hours at 37°C in shaking incubator.  After 8 hours incubation, 
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the LB broth was centrifuged at 2000X g for 15 minutes at 4 °C to obtain E. coli pellet.  
E. coli were washed one time with PBS by centrifugation at 2000X g for 15 minutes at 
4°C and, then inactivated by autoclaving at 121°C for 20 minutes.  E. coli inactivation 
was confirmed by absence of its growth on nutrient agar plate up to 48 hours following 
incubation at 37°C, while integrity of the E. coli cells was confirmed by microscopic 
examination (Olympus, Center Valley, PA).  
To label E. coli with rhodamine, 2-gram of rhodamine was dissolved in 100 ml 
carbonate bicarbonate buffer (pH 9.2). Then the E. coli pellet was dissolved in 
rhodamine-carbonate bicarbonate buffer and incubated for 1 hour at room temperature. 
After the 1-hour incubation, rhodamine-labeled E. coli was washed five times with PBS 
by centrifugation at 2000X g for 15 minutes at 4 °C. Finally, rhodamine labeling to E. 
coli was confirmed using fluorescent microscopy (Olympus, Center Valley, PA).   
To measure the effect of BVDV on neutrophil phagocytosis of E. coli, freshly 
collected bovine neutrophils were infected with either TGAC, TGAN, 1373 or BVDV2a 
28508 at a MOI of 6. Following a 1-hour incubation, BVDV or mock-infected 
neutrophils were washed with PBS and resuspended in RPMI media supplemented with 
10% FBS and antibiotics to achieve final concentration 5x105/ml. One ml of neutrophils 
from each treatment was transferred to 24-well plates, to those wells, rhodamine-labeled-
E. coli were added at 1:10 target effector ratio. Neutrophils were incubated at 37°C for 
hour and washed with PBS as described above. Neutrophils were then fixed with 200 µl, 
1% paraformaldehyde suspended in PBS.  Fixed neutrophils were either transferred to 
individual wells in 24-well plates to determine phagocytosis by fluorescence microscopy 
(Olympus, Center Valley, PA) using the following formula  
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Percent phagocytosis= Number of neutrophils with phagocytized beads X 100/Total 
number of neutrophils  
 
or examined using the FACS Calibur (Becton-Dickson, Mountain View, CA, USA).   
Effect of BVDV on neutrophil oxidative burst activity  
Freshly collected neutrophils were infected with either TGAC, TGAN, 1373 or 
28508 at a MOI of 6 to measure the effect of BVDV on neutrophil oxidative burst 
activity. After one-hour of infection, BVDV or mock-infected neutrophils were washed 
with PBS by centrifugation at 500X g for 10 minutes at 25°C. After washing, the 
neutrophils were suspended in RPMI 1640 medium supplemented with 10% FBS, 
penicillin (100 U /ml) and streptomycin (100 μg /ml) to achieve final concentration as 
1x106 /ml.  The neutrophil suspension (200 µl) from each treatment was then transferred 
to an individual well in a round bottom 96-well plate. Mock-infected neutrophils were 
divided into three groups: 1) positive control (mock-infected neutrophils treated with 
oxidative burst inducer phorbol 12-myristate 13-acetate: PMA); 2) negative control 
(mock-infected neutrophils with no PMA; and 3) DHR 123-negative control [neutrophils 
with no treatment and no dihydrorhodamine 123 (DHR 123)]. The DHR 123-negative 
control was used to set the fluorescence gates on the FACS Calibur flow cytometer.  
Twenty (20) µl of 10 µm dihydrorhodamine 123 (DHR 123) (Sigma-Aldrich, St. 
Louis, MO, USA) was added to each well, except no DHR123 was added to the negative 
control cells.  DHR 123 is colorless dye, which passively enters the cell and produces 
green fluorescent in the presence of reactive oxygen species. After adding DHR 123, 
plates were incubated at 37C for 15 minutes. Following the incubation, 50 µl Phorbol 
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12-myristate 13-acetate (PMA) 10nM was added to each well (except DHR123-negative 
control) and the plate was incubated for 15 minutes at 37C.  After 15 minutes of 
incubation, the plates were washed with PBS and fixed with 1% paraformaldehyde in 
PBS.  The oxidative burst activity in fixed cells were measured using the flow cytometer 
(Becton-Dickson, Mountain View, CA, USA).  
Effect of BVDV on Neutrophil extracellular traps (NETs) formation  
Effect of BVDV on neutrophil extracellular traps (NETs) formation was measured 
through NETosis assay kit (Cayman Chemical, Ann Harbor, MI).  Briefly, freshly 
collected bovine neutrophils were infected with one of the four strains at a MOI of 6 for 1 
hr.  
BVDV or mock-infected neutrophils were centrifuged at 500X g for 10 minutes at 25 °C 
to obtain cell pellet. The neutrophil pellet was resuspended in pre-warmed NET assay 
buffer (prepared by combining 500 ml RPMI medium with 5 grams of bovine serum 
albumin and 500 µl calcium chloride) to achieve final concentration 1x106/ml. A 900 µl 
cell suspension was transferred to individual wells of 24-well plate. One hundred (100) µl 
1X phorbol 12-myristate 13-acetate: PMA (provided with the kit) was added to each well 
and plate was incubated at 37 °C for four hours to induce NET formation. The mock-
infected neutrophils treated with PMA were treated as positive control while mock-
infected neutrophils with no PMA treatment was used as a negative control.  
After the four-hour incubation, the supernatant was aspirated and discarded 
carefully without disturbing the NET-cells. The NET-cells were washed gently with one 
ml NET assay buffer twice.  Five hundred (500) µl of S7 nuclease (1:1000 dilution: 
provided with kit) was added to each well and the plate was incubated for 15 minutes at 
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37°C to digest NET DNA and release neutrophil elastase.  After 15 minutes of 
incubation, the supernatant was collected and placed into a new 1.5 ml tube.  The 10 µl 
500Mm ethylenediaminetetraacetic acid (provided with kit) was added to each tube and 
incubated for one minutes at room temperature to inactivate nuclease. The tubes were 
inverted gently a few times and then centrifuged at 300Xg for 5 minutes at room 
temperature.  One hundred (100) µl of supernatant from each tube was transferred to a 
respective well of flat bottom 96-well plate. The 100 µl neutrophil elastase substrate 
containing 15 mM N-methoxysuccinyl-Ala-Ala-Pro-val-p nitroanilide (provided with kit) 
was added to cell supernatant. The plate was covered with aluminum foil and incubated 
at 1 hour for 37°C.  After the 1-hour incubation, absorbance from each well was 
measured at 405nm using Bioteck ELX808 ELISA plate reader (Thermo Fisher Scientific 
Inc., MA, USA). Each experiment was repeated in at least three different animals to 
determine the effect of BVDV on neutrophil extracellular traps (NETs) formation.  
Statistical analysis:  
A paired T test at 5% level of significance was used to determine the significant 
effect of BVDV on neutrophil migration/chemoattraction, phagocytosis, reactive oxygen 
species production (oxidative burst) or NET formation (Glantz, 2002). 
RESULTS 
Effect of BVDV on neutrophil chemotaxis/ migration ability  
The effect of BVDV on neutrophil chemotaxis activity was measured using 
transwells (Corning life Sciences, Corning, NY).  The number of neutrophil that reached 
the lower chamber were 1509±117.97 for TGAN-infected macrophages, 2836.4±560.97 
for 1373-infected macrophages and 913.2±85.26 for 28508-infected macrophages 
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respectively, which was approximately 139%, 350% and 44% higher as compared to 
mock-infected control neutrophils respectively (Figure 3.3) (p<0.05).  The number of 
neutrophils that migrated after TGAC-infected macrophages were 568.4±208.02 was 
10% less as compared to mock-infected control neutrophils (Figure 3.3) (p<0.05).  Mock 
infection or LPS treatment of macrophage (10ng/ml) resulted in migration of 630±143.94 
and 1818±184.83 neutrophils, respectively (Figure 3.2 and 3.3).  
TGAC, TGAN or 28508 infection reduced the neutrophil migration by 68%, 16% 
and 50% respectively, while 1373 significantly enhanced neutrophil migration by 
approximately 55% as compared to LPS-treated positive control neutrophils (Figure 3.2 
and 3.3) (p<0.05).   
 
Effect of BVDV on neutrophil phagocytic capacity.  
To measure the effect of BVDV on neutrophil phagocytic activity, freshly 
collected neutrophils were infected with one of the 4 BVDV strains at a MOI of 6 for one 
hour. LPS-treated (10ng/ml) or mock-infected neutrophils were used as positive or 
negative controls respectively. After the one-hour incubation, either 0.2 µm red 
carboxylated-modified microsphere beads or rhodamine-labeled E. coli at 1:10 target 
effector ratio was added to the treated or infected neutrophils and incubated an additional 
hour. After the one-hour incubation, phagocytic activity of neutrophil for was measured 
by counting the number of fluorescent beads or rhodamine-labeled-E. coli by fluorescent 
microscope (Olympus, Center Valley, PA) internalized in the neutrophils.  Additionally, 
the phagocytic activity of neutrophils for rhodamine-labeled E. coli was also measured 
using flow cytometry.  
86 
 
BVDV infection by any of the four strains significantly enhanced neutrophil 
phagocytic activity of 0.2 µm microsphere beads (p<0.05) as compared to mock infection 
(Figure 3.4). Phagocytosis activity following TGAC, TGAN, 28508 or 1373 infection 
was approximately 159%, 816%, 384% and 741% higher as compared to mock-infected 
control neutrophils respectively (Figure 3.4). 
Compared to LPS-treated positive control neutrophils, infection with any of the 4 
BVDV strains significantly reduced the phagocytosis of microsphere beads (p<0.05). 
Indicating that BVDV infection compromise the neutrophils’ phagocytic activity during 
bacterial infection as gram negative bacteria contain LPS. Neutrophils infected with 
TGAC, TGAN, 373 and 28508 had phagocytic activity for microsphere beads of 
13.83±4.16%, 48.83±3.34%, 25.83±6.58%, and 44.85±5.77% respectively, which was 
approximately 78.9%, 25.7%, 60% and 31.8% less as compared to LPS-treated 
neutrophils (Figure 3.4).  The phagocytic activity of LPS-treated and mock-infected 
neutrophils was 65.83±6.14% and 5.33±0.52% respectively (Figure 3.4). 
Neutrophil phagocytic activity of rhodamine-labeled E. coli was significantly 
reduced by infection with TGAC, 1373 or 28508 as compared to mock-infected 
rhodamine-labeled E. coli-treated neutrophils (p<0.05).  Neutrophils infected with cp 
BVDV1b TGAC, ncp BVDV2a 1373 or ncp BVDV2a 28508 had less significantly 
phagocytic activity [62.65±7.44% (23% less), 65.92±9.76% (19% less) and 69.92±6.09% 
(12% less) respectively] as compared to mock-infected, rhodamine-labeled-E. coli-treated 
neutrophils with phagocytic activity of 81.29±5.54% (p<0.05) (Figure 3.5).  Neutrophils 
infected with TGAN had less phagocytic activity (76.60±4.59%, 6% less) but not 
significantly lower than the mock-infected control neutrophils (Figure 3.5).  In the current 
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assay, mock-infected-rhodamine-labeled E. coli-treated control neutrophils could also be 
considered as LPS-treated positive control as E. coli contain LPS.   
Additional neutrophil phagocytic experiments were done with rhodamine-labeled E. coli 
using flow cytometry.  The percent geometric mean fluorescence from rhodamine-labeled 
E. coli in neutrophils infected with TGAC, TGAN, 1373 or 28508 was reduced by all 4 
strains (71.45±16.39, 27.8% reduction; 91.03±5.93, 8% reduction; 84.21±10.49, 15% 
reduction and 87.98±11.70, and 11% reduction, respectively) as compared to the mock-
infected rhodamine-labeled E. coli-treated neutrophils that had a geometric mean of 
99.00±13.22 (Figure 3.6).  Among the four strains, cp TGAC infection reduced 
neutrophil phagocytic activity significantly (p<0.05) as compared to mock-infected 
rhodamine-labeled E. coli-treated neutrophils.  
Effect of BVDV infection on neutrophil oxidative burst  
To measure the effect of BVDV infection on neutrophil oxidative burst activity, 
freshly collected neutrophils were infected with one of the four BVDV strains at a MOI 
of 6.  BVDV or mock-infected neutrophils were treated with PMA oxidative burst 
inducer positive control. The neutrophil oxidative burst activity was measured using flow 
cytometry (Figure 3.7).  All strains of BVDV significantly reduced the oxidative burst 
activity in neutrophils (p<0.05). The neutrophil oxidative burst activity was 57.33±3.38% 
(50% less) 55.89±7.32% (51% less) 61.20±4.44% (46% less) and 58.96±5.16% (48%) 
following infection with TGAC, TGAN, 1373 and 28508 respectively (Figure 3.8, Table 
3.1).   Mock-infected-PMA-treated neutrophils (positive control) oxidative burst activity 
was 115.72±3.08%, while mock-infected negative control (no PMA treatment) oxidative 
burst activity was 0.96± 0.02 % (Figure 3.7, Figure 3.8, Table 3.1).  
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Effect of BVDV infection on neutrophil extracellular trap (NETs) activity 
The effect of BVDV infection on neutrophil extracellular traps (NETs) activity 
was measured through NETosis assay kit (Cayman Chemical, Ann Harbor, MI). Freshly 
collected neutrophils were infected with one of the four BVDV strains at a MOI of 6. 
BVDV- or mock-infected neutrophils were treated with PMA as a positive control NET 
inducer. Mock-infected neutrophils treated with PMA were used as a positive control 
while mock-infected neutrophils with no PMA treatment were used as a negative control. 
The four BVDV strains significantly enhanced the NET formation as compared to mock-
infected negative control neutrophils (p>0.05).  NET formation following TGAC, TGAN, 
1373 and 28508 was observed as 102.82±4.83%, 106.91±7.58%, 107.04±6.72 % and 
111.01±10.86% respectively which were  approximately 179%, 190%, 190% and 201% 
higher as compared to  mock-infected negative control neutrophils which showed NET 
formation as 36.87± 0.83% (Figure 3.9, Table 3.1). 
DISCUSSION 
This study was conducted to measure the effect of BVDV infection on neutrophil 
functional activities of migration/chemotaxis, phagocytosis, oxidative burst and NETs 
formation.  The ncp BVDV, TGAN, 1373 or 28508, significantly enhanced neutrophil 
migration by 139%, 350% and 44% higher while cp TGAC reduced neutrophil migration 
as 10% as compared to mock-infected control respectively.  While comparing with LPS-
treated positive control, cp TGAN (68% reduction) and moderately virulent ncp 28508 
(50% reduction) significantly reduced the migration ability of neutrophils (p<0.05).  
TGAN infection reduced neutrophil migration by 16%.  A surprising finding was that the 
highly virulent 1373 enhanced the neutrophil migration by approximately 55%. The cp 
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biotype (cp TGAC) significantly reduced the migration of neutrophils as compared to its 
homologous ncp biotype (TGAN) (p<0.05).  The reduction in neutrophil migration by cp 
TGAC was 62% less than its homologous ncp biotype (TGAN). However, there was no 
significant difference between BVDV type 1 and type 2 on neutrophil phagocytic 
activity.   Surprisingly, the moderately virulent ncp BVDV2a 28508 significantly reduced 
neutrophil migration as compared to the highly virulent BVDV (ncp BVDV2a 1373). 
Higher neutrophil migration following highly virulent 1373 strain infection may be the 
reason of severe leucopenia and hemorrhagic syndrome caused by this virus in vivo 
(Ridpath et al. 2006a, Ridpath et al. 2006b). 
All four strains significantly enhanced neutrophil phagocytic activity for 0.2 µm 
microsphere beads (p<0.05) as compared to mock infection. Phagocytosis activity 
following TGAC, TGAN, 28508 or 1373 infection was approximately 159%, 816%, 
384% and 741% higher as compared to mock-infected control neutrophils respectively. 
Compared with LPS-treated positive control, which simulates gram-negative 
bacterial infection, the four BVDV strains significantly reduced neutrophil phagocytic 
activity of microsphere beads.  Similarly, BVDV infection with all four strains (TGAC, 
TGAN, 1373 and 28508) reduced neutrophil phagocytic activity for rhodamine-labeled E. 
coli and there was little difference between the microscopy and flow cytometry (23% 
vs.27.8, 6% vs 8%, 19% vs 15% and 12% vs 11%).  The higher magnitude of reduction 
in the microsphere assay (TGAC ~3-fold higher; TGAN ~4X fold higher; 1373 ~4X fold 
higher and 28508 ~3X fold higher) between may be due to the difference in targets 
between the two different phagocytosis assays and the high response of the LPS-positive 
control in the microsphere assay. The microsphere beads used in the phagocytosis assay 
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were not coated with any other ligand, and the LPS was added independently to the LPS-
positive control.  However, rhodamine-labeled E. coli had endogenous LPS and LPS has 
been shown to increased neutrophil phagocytosis in a dose-dependent manner (Bohmer et 
al., 1992). Additionally, the size of E. coli (2µm) is 10 times larger than microsphere 
beads (0.2µm). 
A previous study with neutrophils isolated from cp NADL la-infected animals 
also showed decreased paraffin oil uptake as compared to neutrophils isolated from non-
infected control cattle (Roth et al., 1981) supporting the findings of the current study. 
However, in vivo studies did not compare BVDV biotypes or genotypes.  
Previously, our lab also showed that there was a BVDV strain effect on 
phagocytosis with monocyte-derived macrophages (MDM), another phagocytic cell.  In 
that study, both cp and ncp BVDV infection significantly reduced the phagocytic activity 
of MDM for Candida albicans (Elmowalid, 2003; Chase et al., 2004), and such 
phagocytic activity was reduced with course of infection (e.g. 12 hr p.i., 24 hr p.i. and 48 
hr p.i.). That study also showed that moderately virulent 28508, BJ or PA131 did not 
have any effect on MDM phagocytic activity for Candida albicans.  While highly 
virulent 1373, BVDV2-890, Singer, NY-1 or A125 significantly reduced phagocytic 
activity of MDM for Candida albicans at 48 hr p.i. by 51.6%, 54.0%, 59.3%, 72.3% and 
73.2% respectively as compared to mock-infected MDM that had phagocytic activity of 
more than 95%. (Elmowalid, 2003). 
The study showed that all four strains used in study significantly reduced 
oxidative burst activity (p<0.05) by approximately 50% as compared to positive control 
(p<0.05).  BVDV from both biotypes (cp or ncp), genotypes (type 1 or type 2) or 
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virulence (high virulence or moderate virulence) had similar effect on neutrophil 
oxidative burst activity.  There was no significant difference in neutrophil oxidative burst 
activity between BVDV biotypes, genotypes or virulence (p<0.05). Reduced neutrophil 
functional activity following BVDV infected was also observed in a previous in vivo 
experiment.  Neutrophils isolated from MLV (cp BVDV1a Singer) vaccinated animal had 
reduced neutrophil iodination as well as antibody-dependent cell-mediated cytotoxicity 
(ADCC) (Roth and Kaeberle, 1983).   
Our study also showed that BVDV infection significantly enhanced neutrophil 
extracellular trap (NET) formation (p<0.05). NET formation following TGAC, TGAN, 
1373 and 28508 was approximately 179% (102.82±4.83%), 190% (106.91±7.58%), 
190% (107.04±6.72 %) and 201% (111.01±10.86%) higher than mock-infected control 
neutrophils respectively which showed NET formation as 36.87± 0.83%. 
In conclusion, the study measured the strain effect of BVDV on major functions 
of neutrophils. The study used four strains from both genotypes (type 1 and type 2), 
biotypes (cp and ncp), including highly virulent and moderate virulent strains of BVDV. 
Our results indicated that BVDV infection has a significant impact on neutrophil 
functional activity phagocytosis, migration, oxidative burst and NET formation. 
However, in vitro effects can be different than in vivo.  Further in vivo studies need to be 
done to measure the effect of BVDV strains on neutrophil functional activity and overall 
innate immune response. However, it is very difficult to infect neutrophils alone in an in 
vivo system as BVDV infects almost all types host cell, host ranging from epithelial cells 
to cells of innate as well as adaptive immune system. 
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Figure 3.1. Neutrophil transwell migration assay. MDM were seeded and infected 
with BVDV in a 24-well plate (lower part of the transwell plate).  Following incubation 
with the virus, neutrophils were added to the upper chamber of the transwell. The number 
of neutrophils that migrated to the lower well after one hour was used to estimate the 
neutrophil migration ability.  Picture adapted from 
https://www.corning.com/worldwide/en/products/life-sciences/products/permeable-
supports.html. 
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Figure 3.2. Effect of BVDV infection on neutrophil chemotaxis/migration. Five day 
cultured MDM were seeded in the lower chamber of transwell and infected with either 
TGAC (A), TGAN(B), 1373 (C) or 28508 (D) at a MOI of 6 for 1 hour. Mock-infected 
(F) or LPS-treated (10ng/ml) (E) MDM were used as negative or positive controls 
respectively. A 100µl (1x106 cell/ml) of freshly collected neutrophils were seeded in the 
upper chamber of the transwell and allowed to migrate for 1 hour at 37°C. After an one-
hour incubation, the number of neutrophils that migrated to the lower chamber was 
counted by ImageJ software.   
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Figure 3.3. Effect of BVDV infection on neutrophil chemotaxis/migration ability. 
Five day cultured MDM were seeded in the lower chamber of transwell and infected with 
either cp TGAC (A), TGAN(B), 1373 (C) or 28508 (D) at a MOI of 6 for 1 hour.  Mock-
infected (F) or LPS-treated MDM (10ng/ml)(E) were used as negative or positive 
controls respectively.  One hundred (100 µl) (1x106 cell/ml) freshly collected neutrophils 
were seeded at upper chamber of transwell and allowed to migrate for 1hour at 37°C. 
After an one-hour migration, the number of neutrophils reached at lower chamber were 
counted by ImageJ software. Significant difference from LPS treatment was calculated 
through paired T-test (p<0.05) and shown with asterisk sign (*)  
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Figure 3.4. Effect of BVDV infection on neutrophil phagocytosis of 0.2µm beads. 
Freshly collected neutrophils were infected with TGAC, TGAN, 1373 or 28508 at a MOI 
of 6 for 1 hour. Mock-infected or LPS-treated (10ng/ml) neutrophils were used as 
negative or positive controls. After one hour of infection/treatment, neutrophils were 
added to 0.2µm beads with 1:10 target effector ratio. The neutrophil-bead mixture was 
further incubated for one hour and examined for phagocytic activity and the number of 
cells counted using fluorescence microscopy.  Significant difference in neutrophil 
phagocytosis activity from LPS treatment was calculated through paired T-test (p<0.05) 
and shown with asterisk (*)  
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Figure 3.5 The effect of BVDV infection on neutrophil phagocytosis of rhodamine-
labeled E. coli as compared to mock-infected neutrophils. Freshly collected 
neutrophils were infected with TGAC, TGAN, 1373 or 28508 at a MOI of 6 for 1 hour 
while mock-infected neutrophils were used as negative controls. After one hour of 
infection neutrophils were added with rhodamine-labeled E. coli with 1:10 target effector 
ratio. The neutrophil-E. coli mixture was further incubated for one hour and examined for 
phagocytic activity using fluorescent microscope (Olympus, Center Valley, PA).  
Significant differences in neutrophil phagocytosis was calculated with a paired T-test 
(p<0.05) and indicated with an asterisk (*) 
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Figure 3.6. The effect of BVDV on neutrophil phagocytosis of rhodamine-labeled E. 
coli using flow cytometry. Freshly collected neutrophils were infected with cp BVDV1b 
TGAC, ncp BVDV1b TGAN, ncp BVDV2a 1373 or ncp BVDV2a 28508 at a MOI of 6 
for 1 hour while mock-infected neutrophils were used as negative controls. After one 
hour of infection, neutrophils were added to rhodamine-labeled E. coli with 1:10 target 
effector ratio. The neutrophil-E. coli mixture was further incubated for one hour and 
fixed with 1% paraformaldehyde. Fixed cells were examined for phagocytic activity 
using flow cytometry. Significant differences in neutrophil phagocytosis activity from 
mock infection was calculated using a paired T-test (p<0.05) and indicated with an 
asterisk (*) 
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Figure 3.7. Flow cytometry histograms of neutrophil oxidative burst activity 
following BVDV infection. Neutrophils were infected with TGAC (C), TGAN (D), 1373 
(E) or 28508 (F) at a MOI 6 for 1 hr. BVDV or mock-infected (B: positive control) 
neutrophils were treated with PMA. Mock-infected neutrophils with no PMA treatment 
were used as negative control (A). The neutrophil oxidative burst activity in all treatment 
was measured using flow cytometer.  
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Figure 3.8. Neutrophil oxidative burst activity following BVDV infection. 
Neutrophils were infected with TGAC, TGAN, 1373 or 28508 at a MOI 6 for 1 hr.  
BVDV or mock-infected (positive control) neutrophils were treated with PMA. While 
mock-infected and no PMA-treated neutrophils were used as negative control. The 
neutrophil oxidative burst activity in all treatments was measured through FACS Caliber 
(Becton Dickson, Mountain View, CA, USA). Significant reduction in oxidative burst 
activity from positive control cell was calculated using a paired T test (p<0.05) and 
indicated with an asterisk (*). 
 
103 
 
 
Figure 3.9. Neutrophil extracellular trap (NET) formation following BVDV 
infection. Freshly collected neutrophils were infected with TGAC, TGAN, 1373 or 
28508 at a MOI 6 for 1 hr.  BVDV or mock-infected neutrophils were treated with NET 
inducer, PMA.  Mock-infected and PMA-treated neutrophils were used as positive 
control while mock-infected with no PMA treated neutrophils were used as negative 
control.  NET formation was analyzed through enzyme substrate reaction and measured 
at 405nm using a Bioteck ELX808 ELISA plate reader (Thermo Fisher Scientific Inc., 
MA, USA). 
104 
 
 
 Oxidative burst 
activity (%) 
Neutrophil extracellular 
traps (NETs) (%) 
Positive control neutrophils 115.72±3.08 100.00± 4.05%* 
Mock-infected negative control 
neutrophils  
0.96±0.02%* 36.87± 0.83 
Neutrophils infected with cp TGAC (6 
MOI) 
57.33±3.38%* 102.82± 4.83* 
Neutrophils infected with TGAN (6 
MOI) 
55.89±7.32%* 106.91± 7.58* 
Neutrophils infected with 1373 (6 
MOI) 
61.20±4.44%* 107.04± 6.72* 
Neutrophils infected with 28508 (6 
MOI) 
58.96±5.16%* 111.01± 10.86* 
 
Table 3.1. Neutrophil oxidative burst and Neutrophil extracellular traps (NETs) 
formation ability following BVDV infection. Freshly collected neutrophils were 
infected with cp BVDV1b TGAC, ncp BVDV1b TGAN, ncp BVDV2a 1373 or ncp 
BVDV 28508 at a MOI 6 for 1 hr.  BVDV-infected or mock-infected neutrophils were 
treated with the PMA which induced both oxidative burst and/or NET inducer.  Mock-
infected and PMA-treated neutrophils were used as positive control while mock-infected 
with no PMA-treated neutrophils were used as negative control. Neutrophil oxidative 
burst activity was measured through FACS Calibur (Becton-Dickson, Mountain View, 
CA, USA) while NET formation was analyzed through enzyme substrate reaction at 
405nm using Bioteck ELX808 ELISA plate reader (Thermo Fisher Scientific Inc., MA, 
USA).  Significant reduction in oxidative burst activity or NET formation from positive 
control cell was calculated using a paired T test (p<0.05) and indicated with an asterisk 
(*). 
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CHAPTER 4 
 
GENERAL DISCUSSION 
 
Neutrophils are the one of the major white blood cells in circulating blood. 
Neutrophils are considered the first line in the innate immune system (Kobayashi and 
DeLeo, 2009) along with macrophages. Neutrophils play an important role against 
invading bacteria and initiates the adaptive immune responses.  They phagocytize the 
invading microorganisms and activate the innate as well as adaptive immune response. 
Neutrophils activate the immune response through various mediators including 
interleukin-8 (IL-8), platelet activating factor (PAF), leukotriene B4 (LTB4) or 
complement fragment 5a (C5a) (Guo et al., 2003; Mantovani et al., 2011; Mitchell et al., 
2003; Mitchell et al., 2014).  The ability of neutrophils to migrate and destroy the 
invading microorganism depends upon surface maker expression, phagocytic ability and 
oxidative enzymes. Among the surface markers, the cluster of differentiation (CD)-14 
(CD14), CD18 and L-selectin, play an important role against invading organism 
recognition and initiating the immune response (Yoshitake et al., 2002).  A pathogen that 
infects neutrophils could alter its surface marker expression, functional ability and 
significantly affect innate as well as adaptive immune response as discussed in review 
(Drescher and Bai, 2013)   
In the current study, we had three hypotheses: 1) BVDV infection to neutrophils 
significantly affects neutrophil viability in a strain dependent manner; 2) neutrophils 
infected with BVDV have impaired cell surface marker expression of CD14, CD18 and 
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L-selectin; and, 3) altered surface marker expression can result in abnormal functional 
ability including improper migration, phagocytosis activity, chemotaxis ability, oxidative 
burst and/or, altered neutrophil extracellular trap formation. Such changes in neutrophils 
could vary depending on infection with different BVDV biotypes, genotypes or virulence 
types. To address this question, we used four different viruses: a virus pair (biotypes) of 
cp BVDV1b TGAC and ncp BVDV1b TGAN, highly pathogenic ncp BVDV2a 1373 and 
moderately pathogenic ncp BVDV2a 28508.  
The hypothesis of the current study was tested using the following objectives:   
1) To isolate and use bovine neutrophils as an in vitro model to determine effect of BVDV 
on innate immune system. Under this objective three approaches were taken: 
a) Optimize the method for neutrophil isolation from bovine peripheral blood with 
high yields and viability.  
b) Morphological and phenotypic characterization of neutrophils. 
c) Optimize culture conditions for neutrophils.  
2) To investigate the effect of BVDV on neutrophil viability and phenotype. The 
approaches for that objective were: 
a) Study the effect of different biotypes and virulent strains of BVDV on neutrophils 
viability as well as surface marker expression (CD14, CD18 and L-selectin). 
 To investigate the effect of different strains of BVDV on neutrophil functional 
activities of phagocytosis activity, chemotaxis ability, oxidative burst and 
neutrophil extracellular trap formation  
Bovine neutrophils were isolated by gradient centrifugation followed by red blood 
cells (RBCs) lysis and neutrophil restoration. Isolated neutrophils were confirmed 
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morphologically and phenotypically and, further examined for viability, purity and yield.  
The neutrophils had characteristic polymorphic nucleus with 99.80±0.1% purity and 
98.86±0.90 % viability. 
 Neutrophils were CD18+ (99.77±0.13%), L-selectin (97.05±2.41%), and CD14+ 
(11.34±3.89%) positive. A total 20.64±1.89 106 neutrophils were obtained from 50 mL 
peripheral blood (e.g. 10 ml of 2.064±1.89 106/ml neutrophils). None of the BVDV 
strains used in current study cp BVDV1b TGAC, ncp BVDV1b TGAN, ncp BVDV2a 
1373 or ncp BVDV2a 28508 affected the viability of neutrophils in vitro. Trypan blue 
exclusion assay showed neutrophils viability at 98.08± 1.26%, 97.33± 2.08 % and 99.25± 
1.27%, 97.10± 1.09% and 98.50±2.14%, 94.48±0.87% and 98.12±2.22%, 93.97±5.79% 
at 1hr and 6 hr post infection with cp BVDV1b TGAC, ncp BVDV1b TGAN, ncp 
BVDV2a 1373 or ncp BVDV2a 28508 respectively. While unstimulated control cell or 
LPS-treated neutrophils showed viability of 99.17± 1.41%, 98.13± 2.65% and 98.25± 
1.82% and 93.43± 3.08% at 1hr and 6 hr post infection respectively.  
Surface marker expression was measured following BVDV infection revealed that 
both cp BVDV1b TGAC and ncp BVDV1b TGAN increased CD14 expression 
approximately 12% and 27% at 6 hr p.i., respectively, as compared to their unstimulated 
time point control neutrophils. The current study also revealed that ncp BVDV1b TGAN 
infection significantly reduced the CD18 expression (p<0.05) while cp BVDV1b TGAC 
slightly enhanced the expression. Reduction in CD18 expression by ncp BVDV1b TGAN 
was about 24% while increment in CD18 expression by cp BVDV1b TGAC was about 
8% at 6 hr p.i. as compared to their time point control neutrophils.  
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However, both cp BVDV1b TGAC and ncp BVDV1b TGAN significantly 
reduced L-selectin expression at 6 hr p.i. as compared to their time point control 
neutrophils (p<0.05). The reduction in L-selectin at 6 hr p.i. by both biotypes was 
approximately 11% as compared to their time point control neutrophils. 
The effect of BVDV infection on neutrophil functional activity 
migration/chemotaxis, phagocytosis, oxidative burst and NETs formation was measured. 
The neutrophil migration assay was designed to measure the effect of BVDV-infected 
macrophages on neutrophil migration mechanisms (Zec, et al. 2016).  Macrophages acted 
as tissue resident sentinels and attract circulating neutrophils to the site of infection 
(Kolaczkowska and Kubes 2013, Schiwon et al. 2014, Zec et al. 2016). This indirect 
effect of BVDV-infected macrophages on neutrophil migration was measured.   
Cp BVDV1b TGAC infection to macrophage, significantly reduced migration 
ability of neutrophils as compared to mock infected negative control macrophage 
(p<0.05). The reduction in neutrophil migration following cp BVDV1b TGAC was 
approximately 10% less as compared to mock-infected control. While ncp BVDV strains  
BVDV1b TGAN, 1373 and 28508 enhanced neutrophil migration. The number of 
neutrophil that reached the lower chamber were 1509±117.97 for TGAN-infected 
macrophages, 2836.4±560.97 for 1373-infected macrophages and 913.2±85.26 for 
28508-infected macrophages respectively, which was approximately 139%, 350% and 
44% higher as compared to mock-infected control neutrophils respectively.   
The comparative effect of biotypes and virulence revealed that cp biotype (cp 
BVDV1b TGAC) significantly reduced the migration ability of neutrophils as compared 
to its homologous ncp (ncp BVDV1b TGAN) (p<0.05). The reduction in neutrophil 
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migration by cp BVDV1b TGAC was about 62% as compared to its homologous ncp 
(ncp BVDV1b TGAN).  Surprisingly, highly virulent BVDV (ncp BVDV2a 1373) 
significantly enhanced neutrophil migration as compared to moderate virulent BVDV 
(ncp BVDV2a 28508) (p<0.05).  Enhancement of neutrophil migration by highly virulent 
BVDV (ncp BVDV2a 1373) was about 210% higher as compared to moderate virulent 
BVDV (ncp BVDV2a 28508).  Higher neutrophil migration following ncp BVDV2a 
1373 may be the reason for excess tissue injury caused by this virus (Jaeschke and 
Hasegawa 2006, Ridpath et al. 2006, Ramaiah and Jaeschke 2007, Kruger et al. 2015). 
Phagocytic activity was also studied.  All BVDV strains used in the current study 
significantly reduced the phagocytic activity of neutrophils for microsphere beads as 
compared to LPS-treated neutrophils (p<0.05). Neutrophils infected with cp BVDV1b 
TGAC, ncp BVDV1b TGAN, ncp BVDV2a 1373 or ncp BVDV2a 28508 reduced 
phagocytic activity by 78.9%, 25.7%, 60% and 31.8% respectively for microsphere beads 
as compared to LPS-treated neutrophils.  
While comparing with mock-infected control neutrophils, BVDV (e.g. cp 
BVDV1b TGAC, ncp BVDV1b TGAN ncp BVDV2a 1373 or ncp BVDV2a 28508) 
infection significantly enhanced the neutrophil phagocytic activity (p<0.05), which was 
approximately 159%, 816%, 384% and 741% higher as compared to mock-infected 
control neutrophils respectively. 
Similar results were observed with rhodamine-labeled E. coli (E. coli gram 
negative bacteria which contain LPS) was used as target. Neutrophils infected with cp 
BVDV1b TGAC, ncp BVDV2a 1373 or ncp BVDV2a 28508 had a reduction in 
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phagocytic activity of 22.8%, 18.9%, and 13.9% respectively for rhodamine-labeled E. 
coli as compared to mock-infected neutrophils. 
Similar to migration and phagocytic activity, BVDV infection also affected the 
oxidative burst activity in neutrophils. Neutrophils infected with cp BVDV1b TGAC, ncp 
BVDV1b TGAN, ncp BVDV2a 1373 or ncp BVDV 28508 showed approximately 50%, 
51%, 46% and 48% reduction in oxidative burst activity respectively as compared to 
mock-infected-PMA treated neutrophils -  after 1 hr of infection (p<0.05). BVDV from 
both biotypes (cp or ncp), genotypes (type 1 or type 2) or virulence (high virulence or 
moderate virulence) had similar effect on neutrophil oxidative burst activity.  
The PMA-treated BVDV-infected (e.g. cp BVDV1b TGAC, ncp BVDV1b 
TGAN, ncp BVDV2a 1373 or ncp BVDV 28508) neutrophils, increased the oxidative 
burst by 57%, 55%, 61% and 58% respectively as compared with mock-infected 
neutrophils.  
All four of the BVDV significantly enhanced the NET formation as compare to 
mock-infected negative control neutrophils (p>0.05).  NET formation following TGAC, 
TGAN, 1373 and 28508 was observed as 102.82±4.83%, 106.91±7.58%, 107.04±6.72 % 
and 111.01±10.86% respectively which were  approximately 179%, 190%, 190% and 
201% higher as compared to  mock-infected negative control neutrophils, which showed 
NET formation as 36.87± 0.83%.  
There are very limited studies have been done to determine the effect of BVDV 
on neutrophils. In an in vivo study, neutrophils isolated from experimentally BVDV 
infected cattle showed decreased phagocytic activity with reduced paraffin oil uptake as 
compared to neutrophils isolated from non-infected control cattle (Roth et al., 1981).  
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Similarly, neutrophils isolated from persistently infected cattle also showed reduced 
number as well as its functional activity (Brown et al., 1991).  Animals experimentally 
vaccinated with live modified BVDV vaccines also showed similar results with reduced 
neutrophil numbers as well as functional activity (Roth and Kaeberle, 1983). However, 
these studies did not evaluate neutrophil functional activities like migration, 
phagocytosis, oxidative burst, pathogen killing ability or cytokine production. In addition, 
there are no studies, which compared BVDV biotypes, genotypes and virulence on 
neutrophil function making this study unique.  
Another flavivirus, hepatitis C virus (HCV), also cause neutropenia (Yu et al. 
2011, Sheehan et al. 2013) and altered neutrophil function (Hassoba et al. 2010).  
Neutropenia caused by HCV may be due to its infection to pluripotent hematopoietic 
CD34+ cell (Sansonno et al., 1998), resulting reduced neutrophil production or direct 
neutrophil apoptosis through caspases 3 and 10 pathways  (Aref et al., 2011), or by both.  
Study with 24 HCV patients with hemodialysis had significantly reduced neutrophil 
oxidative burst activity before as well as after hemodialysis (Hassoba et al. 2010).  
Measurement of oxidative burst in that study after hemodialysis was performed to avoid 
any effect of uric acid.  
West Nile virus (WNV), another flavivirus behaved differently with neutrophils.  
WNV increased peripheral neutrophil count as observed in case report (Lustig et al. 
2016), with rapid recruitment of neutrophils at site of infection (Bai et al. 2010).  
WNV infected and used neutrophils to transport virus to the  brain (Wang et al. 
2012). Depletion of neutrophils or knockdown of Cxcr2 gene (neutrophil chemokine 
gene) prior to WNV resulted in reduced viremia and enhanced host survival (Bai et al. 
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2010).   Depletion of neutrophils after WNV infections in mice resulted in higher viremia 
with enhanced host mortality (Bai et al. 2010). Results of this study further strengthening 
that WNV used neutrophils for virus transport and disease pathogenesis.   
Although in the same family, HCV and WNV infections result in different 
outcomes in neutrophils. Therefore, a study on effect of BVDV on neutrophil viability 
was done to better understand BVDV pathogenesis.  The current study tried to choose the 
most representative BVDV strains: a virus pair (biotypes) of cp BVDV1b TGAC and ncp 
BVDV1b TGAN from type 1a genotypes and the highly pathogenic ncp BVDV2a 1373 
and moderate pathogenic ncp BVDV2a 28508 were chosen from type 2a genotypes. 
However, there are still number of questions which need to be answered including the 
effects of BVDV on neutrophil toll-like receptors (TLR) and cytokine production, which 
ultimately shapes the adaptive immune response.  The current study showed that highly 
virulent ncp BVDV2a 1373 induced more neutrophil migration, which can result in 
excessive tissue damage. However, the oxidative burst assay revealed that ncp BVDV2a 
1373 reduced neutrophil oxidative activity. There is further need to determine the effect 
of BVDV on other underline mechanisms, which may lead to tissue damage from 
neutrophil protease activity (e.g. elastase, proteinase-3, and cathepsin G). Among the 
various antimicrobial neutrophil products serine proteases plays an important role in 
microbial killing as well as tissue damage (Kruger et al. 2015). 
 Additionally, in the current study, we infected macrophages and observed the 
neutrophils migration.  It will be interesting, if we can infect neutrophils or both 
neutrophils and macrophages and then see the combined effect on neutrophil migration 
and other neutrophil functional activity.  
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